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Abstract  
Environmental stress disrupts cellular homeostasis leading to proteostasis disruptions 
which must be correct by rapid reprogramming of transcription and translation mediated by the 
translation machinery of which tRNA and aminoacyl tRNA synthetases are particularly important.   
Our aim in this study was to conduct a genome-wide RNAi kinase screen of a long-lived and stress-
resistant rrt-1(gc47) (MC240) C. elegans mutant that constitutively, under naïve conditions, 
expresses a GFP reporter for gpdh-1, which is required for survival during hypertonic stress, but 
not expressed under naïve, non-stress conditions. Our approach was to administer RNAi by 
feeding, and we used 382 RNAi clones, including genome-wide kinases, to identify kinases 
required for constitutive expression of gpdh-1 in our MC240 mutant under naïve conditions. We 
identified 250 regulators of gpdh-1 expression with 221 resulting in reduction or complete 
suppression. GO term analysis through DAVID, KEGG, and Reactome pathways indicated 
enriched signaling cascades converged on MAPK activation. Rrt-1 knockdown mediated gpdh-1 
synthesis is regulated by many kinases affecting diverse cellular processes, but primarily involving 
immune system function.  
 
 
Word count: 169 
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Literature Review  
1. Transfer RNA genes are conserved but diverse 
DNA bases are read in 64 nucleotide triplets termed codons, which redundantly encode 20 
amino acids for protein synthesis. During translation, in the process of binding tRNAs to their 
cognate amino acids, diverse tRNA molecules bind the same amino acid (Table 1); tRNA families 
that bind a specific amino acid while having diverse anti-codons are termed isoacceptors. Within 
each isoacceptor family, there are isodecoders that bind the same anti-codon but demonstrate 
diversity in the three hairpin loops characteristic of tRNA (Figure 1) [1]; this facilitates specific 
regulatory control by the cell. 
Amino acid Codon 
tRNA genes including cognate anti-codons 
Caenorhabditis elegans Eukaryota 
Arginine 
Arg 
R 
ACG 19 2448 
CCG 2 697 
CCT 4 1097 
TCG 9 1363 
TCT 8 1610 
Total 42 7215 
Table 1. tRNA genes and species are diverse and redundant for each amino acid.  There are 
42 predicted tRNA molecules or isoacceptors for five codons associated with arginine. For the 
five isoacceptor families of arginine tRNAs, there is a wide range (2-19 in C. elegans) of 
isodecoders for each codon. The variation and redundancy of the genome demonstrates nature’s 
versatility and the potential for regulation of translation by tRNA molecules [2] 
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Noncoding genes for tRNA 
molecules are highly conserved and 
diverse, including thousands of genes for 
the 20 cognate amino acids in multiple 
animal models. In an analysis of 11 
representative eukaryotic genomes, there 
were 170-570 tRNA genes detected with 
41-55 isoacceptors and 10-246 
isodecoders [2]. In C. elegans, there are 42 
predicted tRNA molecules for arginine 
(Table 1) and 7238 different tRNA 
molecules for arginine predicted within 
Eukaryota (Table 2). Conserved tRNA 
gene diversity and data suggest non-canonical roles for tRNA molecules in regulatory processes 
[3]. Observations that tRNA abundance changes during osmotic [4], nutrient [5], and oxidative 
stress [6] suggest tRNAs have roles in stress [7]. 
Arginine, Arg, R 
Rank Clade Number of tRNAs 
Species Caenorhabditis elegans 42 
Genus Caenorhabditis 284 
Family Rhabditidae 284 
Order Rhabditida 502 
Class Chromadorea 502 
Phylum Nematoda 512 
Kingdom Metazoa 2981 
Domain Eukaryota 7238 
Table 2. Taxonomy of predicted tRNA genes for arginine.  
  
Figure 1. tRNA structure is conserved despite significant sequence 
variation.  The sequence of C. elegans tRNA Arginine is shown with 
the conserved sequences given in standard single letter code, varied 
regions are blank.  There is significant variation within the molecule, but 
the functional regions are highly conserved.  In the middle of the 
diagram we see many conserved sequences as expected as those 
nucleotides interact with many binding partners and any mutation would 
likely cause structural changes impacting molecular function.  
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2. Abnormal tRNA charging is related to the pathophysiology of many diseases. 
 tRNA molecules are bound to cognate amino acids by specific aminoacyl synthetases 
(aaRS) in a reaction consuming ATP (Figure 2). Distinct stress-related tRNA isoacceptor charging 
is regulated by mechanisms not yet understood, but include aaRS [8], the tRNA pool [9], and 
depletion of cognate amino acids [5]. Canonically, aaRS function in the cytoplasm as part of a 
multi-enzyme complex [10] or as individual molecules [11] to precisely charge tRNA molecules. 
Mis-charged tRNA molecules by non-cognate aaRS [12] may be edited by cognate aaRS [13] or 
inappropriately incorporated into protein resulting in mistranslation and protein degradation [14]. 
Figure 2. Aminoacyl tRNA synthetases (aaRS) charge cognate tRNA molecules in a two-step reaction requiring ATP. In the 
first step of the aaRS reaction, the aaRS enzyme binds the cognate amino acid and ATP. Then, tRNA isoacceptors are charged with 
the amino acid consuming ATP. Proofreading may occur pre-transfer or post-transfer at active or trans-editing sites. 
 
© 2019 International Union of Biochemistry and Molecular Biology. Used with permission. 
 In addition to ligation and editing, aaRS function in immune regulation [15, 16], 
inflammation [17, 18], autophagy [19], apoptosis [20], cellular growth and proliferation [21], 
oncogenesis [22, 23], translation [24], post-translational modifications [25], transcriptional 
regulation [26], cell stress responses [27, 28], and angiogenesis [29, 30] (Figure 3) [31]. Several 
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neurological diseases have links to aaRS gene mutations [32] with diverse pleiotropic effects  [33]. 
For example, a mutation in the editing domain of alanyl-tRNA synthetase causes protein 
misfolding and cell death underlying neurological dysfunction [34]. This is not a comprehensive 
description of aaRS [35] and many functions have been discovered in the last two decades 
demonstrating a rapidly evolving understanding of the important role aaRSs serve [35-37]. 
Figure 3. Aminoacyl tRNA synthetases 
(aaRS) have many non-canonical roles in 
cellular signaling.  aaRS proteins exist in the 
cytoplasm individually or as part of a multi-
enzyme complex, which may facilitate 
substrate shuttling. aaRS have signaling roles 
participating in immune activation, 
transcription, apoptosis, oncogenesis, and cell 
stress responses.  
(EP: glutamyl-prolyl-, I: isoleucyl-, L: leucyl-, 
M: methionyl-, Q: glutaminyl-, R: arginyl-, K: 
lysyl-, and D: aspartyl-tRNA synthetase), 
apoptosis signal-regulating kinase (ASK) far 
upstream element-binding protein (FBP)  
 
© 2019 Hyeon et al. 
 
 
 
 
3. Many pathways regulate tRNA charging. 
Several pathways in diverse cellular processes regulate tRNA charging. At the simplest 
level, starvation of the tRNA’s cognate amino acid reduces the charged fraction [5]. In some 
instances, the cell adapts to maintain the charged fraction while maintaining stress signaling; thus, 
tRNA charging or amino acid levels are not indicative of adequate nutrients [38]. In some bacteria, 
aaRS regulate tRNA charging to prevent amino acid toxicity [39, 40]. The depletion of specific 
amino acids causes selective charging among the tRNA isoacceptor families [5] as well as 
alterations in the charging level of non-cognate tRNA [4]. The variation in charging levels is likely 
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due to changes in post-transcriptional processing [41], transcription rate [42], degradation rate [43, 
44], aaRS binding affinity/selectivity and tRNA fragments [45].   
Accumulated uncharged tRNA molecules bind and activate general control 
nonderepressible kinase 2 (gcn-2), which 
phosphorylates eIF2α to inhibit protein translation 
[46]. Inhibition of protein translation rate decreases 
the rate of tRNA discharging, which maintains the 
charged fraction during amino acid starvation [47]. 
Diverse cellular processes activate eIF2α, including 
endoplasmic reticulum (ER) stress induced by the 
unfolded protein response (UPR), heavy metal 
toxicity, and double-stranded RNA (dsRNA) (Figure 
4) [rev. in 48]. Growth, developmental processes, and 
various stressors induce specific tRNA transcriptional profiles [49]. Initial investigations 
discovered alterations in charging patterns in response to hormones [50, 51], viral infections [52], 
developmental signals [53], proteasome inhibition[54], and in cancerous cells [rev. in 55], which 
may be mediated by aaRS regulation [31]. Fundamental biological processes are affected by tRNA 
and aaRS function and are affected by cellular stress responses demonstrating their integral role in 
cellular survival and adaptation.  
4. Stress-induced [tRNA] changes impact multiple biological/metabolic pathways. 
 Cells adapt to changing environments through stress-responsive gene expression [45, 56, 
57]. Stress-related genes use rare codons at higher rates and may be transcribed by non-canonical 
mechanisms, including alternate start sites and frameshifts [58]. Differential charging of the tRNA 
Figure 4. Changes in amino acid levels activate 
canonical stress response signaling pathways.
Phosphorylation of eIF2α is mediated by four known 
protein kinases and inhibits eIF2B activity which inhibits 
mRNA translation. 
 CC BY 2.0.Used with permission. 
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pool alters translation of mRNA transcripts proportionally to codon composition, increasing 
translation of stress-related codons while simultaneously reducing global translation [5, 58]. 
Selective isoacceptor charging in response to stress is evolutionarily conserved from yeast [4, 5] 
to humans [59]. tRNA serve as essential mediators in the regulation of stress-responsive 
translation. 
The tRNA pool includes mature tRNA molecules, charged and uncharged, tRNA halves 
and fragments, tRNA pseudogenes and a variety of post-transcriptional modifications (PTM), all 
of which have distinct signaling roles [7, 45, 60]. Biogenesis, sub-cellular trafficking, degradation, 
and post-transcriptional processing of tRNAs are altered in response to various environmental 
stressors and growth conditions (Figure 5) [rev. in 61]. During stress, the upregulation of the 
RNAse angiogenin mediates rapid tRNA cleavage [45, 62]. tRNA fragments inhibit protein 
synthesis independent of eIF2α, possibly by displacing eIF4F and inducing the assembly of stress 
Figure 5. Diverse stressors induce 
changes in tRNA biosynthesis and 
post-transcriptional processing. The 
canonical tRNA biogenesis pathway is 
indicated with solid black arrows.  A. 
Nutrient and temperature stress likely 
inhibit 3’ trailer sequence processing 
which results in accumulation of 
aberrant pre-tRNAs. B. Varied 
stressors cause changes in post-
transcriptional modifications of tRNA 
which may affect their activity and 
affinity for translational machinery. C. 
Nutrient deprivation inhibits tRNA 
transport out of the nucleus. D. 
Oxidative stress induces removal of the 
3’ CCA terminal thus inhibiting 
binding to cognate amino acids. E-G. 
Various stressors have been shown to 
induce specific cleavage and 
accumulation of tRNA molecules with 
the enzymes Dicer, angiogenin, and 
other RNAse A family members 
mediating this cleavage. The 
implications of these tRNA fragments 
are not fully understood.  
CC BY 4.0, Huang, 2016 
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granules [61]. During osmotic stress, tRNA halves may inhibit stress-induced apoptosis by binding 
to cytochrome c [63]. There are more than 120 different PTMs, ranging from single methylation 
to multi-step reactions [60, 64]. PTMs support translation fidelity, proteome maintenance, tRNA 
folding and stability, wobble pairing, and tRNA specificity [rev. in 61]. tRNA PTMs are a 
mechanism for the cell to rapidly regulate translation of critical response proteins necessary for 
survival [65]. The tRNA pool is regulated in multiple ways by diverse mechanisms and participates 
in the regulation of many biological processes, 
including stress responses.  
5. tRNA signaling and other stress response 
pathways converge to regulate protein 
translation at the translation initiation 
complex. 
Disturbances to proteome integrity 
from environmental stressors and infection 
cause an adaptive stress response mediated by 
changes in tRNA PTM, fragments, 
degradation, and charging levels, which alter 
translation initiation and elongation [6]. In 
theory, selective translation of critical stress 
proteins conserves energy to focus on adapting 
to or resisting the current stressor.  
In mammals, four distinct kinases 
activate the integrated stress response (ISR) 
Figure 6. Phosphorylation of eIF2α by stress-induced kinases 
inhibits translation initiation complex formation. Stress‐mediated 
eIF2α phosphorylation results in global translational inhibition, 
stimulates stress granule assembly, and promotes translation of stress‐
responsive mRNAs.  
B. Mammalian target of rapamycin (mTOR)C1 is a positive regulator 
of translation. Increased activity of mTORC1 phosphorylates 
translational repressor eIF4E‐binding proteins (4E‐BPs) and 
ribosomal S6 kinases (S6K1/2). These phosphorylation events 
regulate translation of 5’-terminal oligopyrimidine tracts (TOPs)/TOP 
like mRNAs. Treatment with mTOR inhibitors (e.g., rapamycin or 
Torin) or starvation conditions decreases the activity of mTORC1, 
thus inhibiting translation and promoting stress response.  
 
Used with permission ©John Wiley and Sons.  
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(Figure 6) [rev. in 66]. They include heme‐regulated inhibitor kinase (HRI) [67], protein kinase 
RNA (PKR) [68], general control nonderepressible‐2 (GCN2) [69], and PKR‐like ER kinase 
(PERK) [70]. HRI is activated during oxidative stress [67], low levels of heme [71], osmotic stress 
[67], and heat shock [67]. PKR is activated by double‐stranded RNAs [72] and serves an important 
role in innate immunity to viral infection [73]. GCN2 is activated by UV irradiation [74] in addition 
to uncharged tRNA binding due to amino acid starvation [46, 69]. PERK is activated by ER stress 
[75], proteostasis disruptions [76], and hypoxia [77].  
6. Arginyl-tRNA synthetase deficiency causes a unique and robust resistance to osmotic, 
hypoxic, heat, and other stressors. 
 Arginyl-tRNA synthetase (rars-1, rrt-1) deficiency induces resistance to osmotic stress 
[78] and hypoxic stress [79]. This mutant/RNAi clone was identified by two independent 
investigators examining organismal resistance to two unique stressors.  The work of Strange and 
colleagues illustrated that this mutant was robustly resistant to osmotic stress challenges through 
increased proteostasis capacity.  As discussed earlier, Anderson et al. demonstrated rrt-1 improved 
survival after a hypoxic challenge with RaaRS showing the most robust response [79]. Why rrt-1 
is uniquely important to stress response and adaptation remains unknown. 
 In an examination of aa restriction in human cells or C. elegans, investigators discovered 
that C. elegans uniquely requires arginine to remain viable [80].  C. elegans, through the enzyme 
arginine kinase, utilizes arginine as an intracellular energy buffer similar to the creatine 
kinase/creatine pair in humans and other mammals [81].  In addition, arginine kinase-1 (ARGK-
1) is necessary for the longevity extension effects of S6 kinase (S6K) rsks-1 mutant worms and 
overexpression of ARGK-1 alone was sufficient to extend lifespan [81].  This evidence could 
indicate that RaaRS interference impacts cellular energy metabolism through reduced tRNA 
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charging and alterations to the available levels of free arginine. While this is an exciting 
hypothesis, there is minimal evidence for the role of arginine in energy metabolism [82] and very 
little evidence to indicate RaaRS impacts the use of arginine for energy [83]. Inhibition of RaaRS 
caused the highest increase in fat storage of the aaRS genes at a 3-fold elevation [83], and aaRS 
with similar fat storage demonstrated a 150% increase in starvation survival time. The longevity 
effects of S6K [81] and ARGK-1 [84], as well as the starvation survival, required AMPK activation 
[83]. 
7. Genome-wide screens in C. elegans using RNA interference has elucidated genome-wide 
regulators of stress response gene expression 
 Caenorhabditis elegans is a unique model due to its self-reproduction, which allows the 
examination and maintenance of large numbers of genetically homogenous worms [85]. This 
homogeneity, coupled with the discoveries of RNA interference (RNAi) by Fire [86] and the 
subsequent genome-wide RNAi libraries created by Vidal [87] and Ahringer [88] allowed for the 
interrogation of molecular pathways in C. elegans. These libraries, coupled with the mutant 
libraries maintained by the Caenorhabditis Genetics Center, allowed for the examination of 
fundamental molecular pathways. The Vidal and Ahringer libraries collectively contain ~20,000 
clones to interfere with 94% of known protein-coding genes in C. elegans. A sub-library (382) of 
these genes has been selected, which encodes for genes with predicted kinase functionality. This 
enriched subset of protein kinase genes serves as a pool of the primary signaling mechanisms in 
C. elegans. These kinases are involved in many fundamental processes and this sub-library is thus 
an excellent starting point for initial genetic screening.  
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Introduction 
 Cellular survival requires shifts in transcription and translation of genes necessary for 
growth and maintenance to those required for stress survival and adaptation. The cellular transfer 
RNA (tRNA) pool mediates the translation of the genetic code into functional proteins. The tRNA 
pool contains all the active tRNA molecules, tRNA halves, tRNA fragments, and inactive tRNA 
molecules and possibly tRNA pseudogenes. Specific aminoacyl-tRNA synthetases (aaRS) ligate 
or charge tRNA molecules with their cognate amino acid. aaRS participate in signaling cascades 
involving cancer, apoptosis, stress resistance, starvation survival, and proteostasis.  
 Multiple genome-wide screens have revealed that aaRS serve essential roles in stress 
survival primarily through their effects on proteostasis. Two genome-wide RNAi screens [89, 90] 
identified regulators of osmoprotective gene expression (rgpd genes, regulators of gpdh-1), which 
include genes encoding essential translation machinery components, including many aaRS. A 
screen for hypoxia resistance found that arginyl aaRS (rrt-1) resulted in profound hypoxia 
resistance with rrt-mutants surviving at a 100% survival rate [79]. A genome-wide screen for 
regulators of fat storage found that aaRS resulted in a 3-fold increase in fat storage, which allowed 
for a 150% increase in survival time.  
  Our aim in this study was to conduct a genome-wide RNAi kinase screen of a long-lived 
and stress-resistant rrt-1(gc47) (MC240) C. elegans mutant that constitutively, under naïve 
conditions, expresses a GFP reporter for gpdh-1, which is required for survival during hypertonic 
stress, but not expressed under naïve, non-stress conditions. Our approach was to administer RNAi 
by feeding, and we used 382 RNAi clones, including genome-wide kinases, to identify kinases 
required for constitutive expression of gpdh-1 in our MC240 mutant under naïve conditions.  
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Methods 
 C. elegans strains. We obtained the following strain from the Caenorhabditis Genetics 
Center (University of Minnesota, Minneapolis, MN): wild-type N2 Bristol. MC240 (rrt-1(gc47)) 
was provided by the Crowder laboratory. OG119 drIs4[col12p::dsRed;gpdh-1p::GFP] was 
provided by the Strange laboratory. VP611 drIs4[col12p::dsRed;gpdh-1p::GFP]x(rrt-1(gc47)) 
worms were generated by mating male (7% ethanol treatment, 30 minutes) OG119 to 
hermaphrodite MC240 and selecting for worms that exhibit constitutive gpdh-1::GFP. Worms 
were cultured at 20C using standard methods [89].  Hypertonic agar plates were made by adding 
additional NaCl to standard nematode growth media [78]. 
RNAi experiments. RNAi was performed by feeding worms a strain of Escherichia coli 
engineered to transcribe dsRNA targeted to a C. elegans protein-coding gene. The strains were 
derived from a commercially available RNAi feeding library (Geneservice, Cambridge, UK). The 
protein kinase sub-library (from the Ahringer and Vidal libraries) used in this initial screen was 
generously provided by Dr. Kevin Strange (Mount Desert Island Biological Laboratory, Salisbury 
Cove, ME). An “empty vector” bacterial strain expressing 202 bases of dsRNA not homologous 
to any predicted C. elegans gene was used as a control for non-specific RNAi effects [78]. Single 
RNAi bacterial colonies from overnight growth and were inoculated into 100 μl of LB media 
containing 25μg∙mL-1 carbenicillin and 25μg∙mL-1tetracycline and grown for 24hours (h) at room 
temperature.  Ten microliters (μL) of each culture and control clones were spotted onto individual 
wells of 48-well nematode growth media (NGM) agar plates containing 51mM NaCl, 1mM β-
lactose, 25μg∙mL-1 carbenicillin, and 25μg∙mL-1 tetracycline.  After overnight induction (12-18h, 
37C), 10-20 L1 stage worms were dispensed in 5-10uL drops.  GFP expression was monitored 
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visually after ~72h (20C) using a fluorescent microscope (V12 Discovery, Zeiss, Thornwood, 
NY). 
 VP611 worms carrying the rrt-1(gc47) allele constitutively express osmoprotective gpdh-
1 and GFP. Worms were assessed when they reached the L4 stage at ~72h after L1s were placed 
on RNAi growth media. Of note, as expected, RNAi of some kinases impacted growth rates.  
Worms were evaluated for growth, gross morphology, dsRed control (cuticular protein, col-12) 
reporter expression, and gpdh-1p::GFP expression. Life cycle differences and GFP expression 
were qualitatively assessed and used to determine the validity of repeat screens. Worms were 
scored as: 1) complete loss of green (knockdown) correlating to control worms fed GFP dsRNA, 
2) partial but significant loss (diminisher) correlating to control worms fed gpdh-1 RNAi, 3) 
increased green fluorescence (enhancer), 4) and no change correlated to worms fed non-specific 
dsRNA. Control RNAi were present on every plate and were used to generate a standard curve by 
which fluorescence to account for between plate variations.   
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 Results 
 We screened RNAi effects of 382 protein kinase genes in triplicate through fluorescence 
microscopy. The initial screen resulted in 255 total regulators of gpdh-1 in rrt-1(gc47) mutant 
(VP611), with the majority of genes categorized as complete reduction of gpdh-1::GFP (140) or 
partial reduction of gpdh-1::GFP (91). 24 RNAi clones were classified as enhancers (24) of gpdh-
1::GFP. The complete list of kinases screened, and screen results are included in the appendix 
(Table 23, and 24). 
 
All RNAi clones were screened in triplicate. We 
completed four screens for the first plate of the RNAi kinase sub-
library (Table 3), 250 total hits, 120 knockdowns, 101 
diminisher, and 29 enhancers, and we utilized the results of the 
first screen augmented with plate one triplicate screening for data 
analysis.  The screening will continue in triplicate and will be 
confirmed through quantitative PCR (qPCR) to verify changes in 
mRNA expression are in line with qualitative observations.   
1. The protein kinase sub-library covers 72% of the predicted C. elegans kinome. 
 We recognized the protein kinase sub-library lacked several known kinases. We 
examined the Vidal (V) and Ahringer (A) libraries for genes with predicted kinase function. The 
Ahringer library contains 19,763 unique genes listed by sequence names, which we converted to 
WormBase ID (WB ID) with WormBase Converter (release 210) [91]. This conversion resulted 
in 16465 WB IDs, with 2516 terms not found, submitted to DAVID for analysis [92]. We then 
extracted the molecular function (MF) direct annotation table to obtain WB IDs annotated with 
Screen Initial Rescreen 
Library 382 382 
Knockdown 140 120 
Diminisher 91 101 
Enhancer 24 29 
Regulators 255 250 
Table 3. The initial screen 
results indicated a 
significant number of hits, 
and rescreening plate 1 in 
triplicate only altered the 
results slightly. 
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GO terms protein kinase activity (359) and protein tyrosine kinase activity (74), resulting in 360 
unique terms with 73 duplicates removed (DR). There were no other kinase-associated terms 
found in the MF data. The Vidal library (ORFeome) contained 11699 unique terms, which we 
converted to WB ID resulting in 10825 WB IDs and 180 terms not found. We extracted MF 
direct data and extracted WB IDs for GO terms kinase activity (223), protein kinase activity 
(211), and protein serine/threonine kinase activity (190), resulting in 306 unique terms with 297 
DR (Table 4). Of the 382 terms in the PK library, 378 unique terms converted to 378 WB IDs. 
DAVID analysis of the PK library indicated 98.6% of terms had protein kinase activity (360); 
thus, we combined this set with protein serine/threonine kinase activity (232), and kinase activity 
(206) which resulted in 363 unique terms with 434 DR.   
data set # terms # WormBase IDs not found unique kinase terms 
Ahringer 19763 16476 2504 360 
Vidal 11699 10825 180 306 
Uniprot 440 435 2 435 
PK sub-library 382 378 0 363 
Original PK sub-library 415 409 0 409 
PK/V 
 
460 
A/V 479 
A/V/PK 494 
A/V/PK/UP (ALL) 520 
ALL/OPK  534 
Table 4. A comparison of commercially available RNAi libraries and annotated kinase sets 
generated a complete set of predicted kinases. Individual library comparisons illustrate library 
overlap. 
The resultant lists of kinase-associated terms were combined PK/V 460 terms (210 DR), 
A/V 479 terms (187 DR), and then A/V/PK 494 terms (536 DR). This analysis indicated there 
were terms present in either library, not found in the PK library subset. The original C. elegans 
kinome, published by Manning [93], contains 438 proposed kinases. A subsequent analysis 
utilizing the UniProtKB knowledgebase by Zaru [94] provided 440 terms, which converted to 
435 unique WB IDs with two terms not found. Combining this data set with the A/V/PK data set, 
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we generated a list of 520 unique WB IDs (410 DR). Comparing this data set to the DAVID 
annotated kinases in the PK library resulted in 159 unique terms missing from the PK library 
subset 129 of which are in A/V libraries with 29 unique terms found only in UniprotKB data set. 
We then compared the original protein kinase sub-library data containing 416 kinases, 409 
unique WB IDs, which increased the unique number of terms to 534 and reduced missing unique 
terms to 125 in total; 105 in the A/V libraries and 20 unique to the UniprotKB data-set. Thus, the 
updated C. elegans kinome may contain 534 terms. However, we reran the UniProtKB search 
utilizing the identifier IPR000719 for kinase domains used by Zaru et al., which returned 593 
kinase terms with 195 reviewed and 398 unreviewed [95]. This number is slightly higher than the 
573 found by Zaru et al. in 2017, which the authors were able to reduce to 413 through isoform 
removal, which is beyond the scope of this paper. This combined kinome illustrates that the 
PK library covered approximately 72% of the predicted C. elegans kinome, and this 
number will likely change as the field advances.   
2. DAVID functional annotation confirms library kinase function and illustrates involvement 
in diverse cellular processes.  
We used DAVID gene functional classification tool [92] to determine whether there are 
enriched terms related to cellular component (CC), biological process (BP), and molecular 
function (MF), and Kyoto encyclopedia of genes and genomes (KEGG) functional pathways in 
our gene lists and functional groups to highlight broad mechanisms that might regulate rrt-1 control 
of cytoprotective gpdh-1 expression. 
To establish a reference list of GO terms and KEGG pathways, we analyzed the 
selected protein kinase sub-library. The kinase sub-library (382 genes) significantly associated 
with MF GO terms: protein kinase activity, kinase activity, and nucleoside/nucleotide binding. 
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(>98%). This result validates the expected function of RNAi clones in the sub-library and allowed 
us to exclude these terms from downstream analysis (Table 5). The sub-library utilized was 
selected for genes with specific molecular functions, thus excluding the terms that are found in 
100% of the genes in the sub-library allows us to focus our analysis on significant differences 
within the gene set.   
GO terms protein serine/threonine kinase activity (67%) and protein tyrosine kinase 
activity (21%) were significantly enriched along with several related MF, including 
transmembrane receptor protein kinase activity (5%) and receptor signaling protein activity (12%) 
(Table 6). These results indicate that a subset of genes in the library is involved in cellular signal 
transduction primarily through serine/threonine/tyrosine kinase binding activity. This overview 
suggests we should expect, in downstream analyses, to see these pathways represented, and the 
exclusion of a pathway in further analyses may be of more interest than a similar representation to 
the data here.   
A small subset of MF terms (2-3%) was related to calmodulin and calcium-binding and 
signaling, including calcium-dependent protein serine/threonine kinase activity. Signaling 
involving MAPK kinase activity (3%) and associated upstream and downstream signals were 
enriched (1%) at all levels of regulation, including Jun kinase activity (1%). Cyclic nucleotide-
binding and cyclase activity (6%), specifically involving guanylate cyclase activity (6%) and 
adenylate cyclase activity (6%), were enriched at several levels, including nucleotide-binding 
(7%).  Several other terms did not fit into a functional category, including phosphorous oxygen 
lyase activity (6%) and histone kinase activity (1%).   
 GO term analysis by BP and CC confirmed our kinase sub-library list participated in 
diverse cellular processes. CC enriched terms included cytoplasm, nucleus, and plasma membrane-
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associated terms (appendix, Table 26). GO terms in BP were numerous (121) and extremely varied, 
illustrating that the kinases were involved in diverse cellular functions, including response to 
wounding, immune system process, and hyperosmotic response (appendix, Table 25). Notably, 
many of these processes were part of systems involved in the cellular stress response to 
environmental and immune stressors.  This analysis confirms our expectations that the curated 
kinase sub-library has annotated kinase activity and represented most cellular processes.   
 
 
GO Term Enriched Term % p-value Fold Enrichment Bonferroni Benjamini FDR 
GO:0097367 carbohydrate derivative binding 99% 0.00E+00 7.09 0.00E+00 0.00E+00 0.00E+00 
GO:0035639 purine ribonucleoside triphosphate binding 99% 0.00E+00 7.71 0.00E+00 0.00E+00 0.00E+00 
GO:0016773 phosphotransferase activity, alcohol group as acceptor 99% 0.00E+00 16.69 0.00E+00 0.00E+00 0.00E+00 
GO:0030554 adenyl nucleotide binding 99% 0.00E+00 9.19 0.00E+00 0.00E+00 0.00E+00 
GO:0005524 ATP binding 99% 0.00E+00 9.21 0.00E+00 0.00E+00 0.00E+00 
GO:0032550 purine ribonucleoside binding 99% 0.00E+00 7.71 0.00E+00 0.00E+00 0.00E+00 
GO:0001883 purine nucleoside binding 99% 0.00E+00 7.71 0.00E+00 0.00E+00 0.00E+00 
GO:0032555 purine ribonucleotide binding 99% 0.00E+00 7.66 0.00E+00 0.00E+00 0.00E+00 
GO:0016301 kinase activity 99% 0.00E+00 14.80 0.00E+00 0.00E+00 0.00E+00 
GO:0032549 ribonucleoside binding 99% 0.00E+00 7.69 0.00E+00 0.00E+00 0.00E+00 
GO:0032559 adenyl ribonucleotide binding 99% 0.00E+00 9.20 0.00E+00 0.00E+00 0.00E+00 
GO:0017076 purine nucleotide binding 99% 0.00E+00 7.66 0.00E+00 0.00E+00 0.00E+00 
GO:0001882 nucleoside binding 99% 0.00E+00 7.68 0.00E+00 0.00E+00 0.00E+00 
GO:0004672 protein kinase activity 99% 0.00E+00 18.97 0.00E+00 0.00E+00 0.00E+00 
GO:0032553 ribonucleotide binding 99% 0.00E+00 7.56 0.00E+00 0.00E+00 0.00E+00 
GO:1901265 nucleoside phosphate binding 99% 5.39E-304 6.19 1.02E-301 3.40E-302 6.69E-301 
GO:0000166 nucleotide binding 99% 5.39E-304 6.19 1.02E-301 3.40E-302 6.69E-301 
GO:0036094 small molecule binding 99% 3.44E-299 6.03 6.51E-297 1.63E-297 4.28E-296 
GO:1901363 heterocyclic compound binding 99% 4.22E-174 2.92 7.98E-172 1.60E-172 5.24E-171 
GO:0097159 organic cyclic compound binding 99% 2.25E-173 2.91 4.24E-171 7.07E-172 2.79E-170 
Table 5. Molecular function GO term analysis of the kinase sub-library indicates all genes are associated with kinase functions 
as expected. These terms are present in all further sub-divisions of the library and are excluded from subsequent analyses. 
 
GO Term Enriched Term % p-value Fold Enrichment Bonferroni Benjamini FDR 
GO:0004674 protein serine/threonine kinase activity 67% 1.62E-307 18.47 3.06E-305 
1.53E-
305 
2.01E-
304 
GO:0004702 receptor signaling protein serine/threonine kinase activity 12% 9.72E-54 22.04 1.84E-51 2.30E-52 1.21E-50 
GO:0004693 cyclin-dependent protein serine/threonine kinase activity 2% 1.52E-09 24.09 2.87E-07 1.51E-08 1.89E-06 
GO:0097472 cyclin-dependent protein kinase activity 2% 1.52E-09 24.09 2.87E-07 1.51E-08 1.89E-06 
GO:0004712 protein serine/threonine/tyrosine kinase activity 2% 6.86E-07 24.09 1.30E-04 6.17E-06 8.52E-04 
GO:0004713 protein tyrosine kinase activity 21% 3.11E-95 21.08 5.89E-93 8.41E-94 3.87E-92 
GO:0004715 non-membrane spanning protein tyrosine kinase activity 12% 6.91E-50 20.65 1.31E-47 1.31E-48 8.58E-47 
GO:0004714 transmembrane receptor protein tyrosine kinase activity 4% 8.23E-17 22.48 2.10E-14 1.44E-15 1.33E-13 
GO:0019199 transmembrane receptor protein kinase activity 5% 2.27E-15 14.12 4.20E-13 2.46E-14 2.75E-12 
GO:0005102 receptor binding 11% 9.16E-17 4.77 2.10E-14 1.33E-15 1.33E-13 
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GO:0005057 receptor signaling protein activity 12% 1.33E-52 20.78 2.51E-50 2.79E-51 1.65E-49 
GO:0019900 kinase binding 2% 1.11E-02 2.93 8.79E-01 6.38E-02 1.29E+01 
GO:0004871 signal transducer activity 17% 3.64E-03 1.42 4.98E-01 2.35E-02 4.43E+00 
GO:0019901 protein kinase binding 2% 1.03E-02 2.97 8.57E-01 6.09E-02 1.20E+01         
GO:0004683 calmodulin-dependent protein kinase activity 2% 5.63E-08 17.52 1.06E-05 5.32E-07 6.99E-05 
GO:0010857 calcium-dependent protein kinase activity 2% 6.86E-07 24.09 1.30E-04 6.17E-06 8.52E-04 
GO:0009931 calcium-dependent protein serine/threonine kinase activity 2% 6.86E-07 24.09 1.30E-04 6.17E-06 8.52E-04 
GO:0005516 calmodulin binding 3% 2.83E-06 6.79 5.35E-04 2.43E-05 3.52E-03         
GO:0004707 MAP kinase activity 3% 3.35E-12 20.38 6.33E-10 3.52E-11 4.16E-09 
GO:0004708 MAP kinase kinase activity 1% 2.73E-04 24.09 5.03E-02 1.84E-03 3.38E-01 
GO:0004709 MAP kinase kinase kinase activity 1% 2.73E-04 24.09 5.03E-02 1.84E-03 3.38E-01 
GO:0031435 mitogen-activated protein kinase kinase kinase binding 1% 1.57E-02 14.45 9.50E-01 8.68E-02 1.79E+01 
GO:0008545 JUN kinase kinase activity 1% 8.11E-02 24.09 1.00E+00 3.67E-01 6.50E+01 
GO:0004705 JUN kinase activity 1% 8.11E-02 24.09 1.00E+00 3.67E-01 6.50E+01         
GO:0009975 cyclase activity 6% 5.20E-21 14.21 9.84E-19 7.57E-20 6.46E-18 
GO:0004691 cAMP-dependent protein kinase activity 1% 8.11E-02 24.09 1.00E+00 3.67E-01 6.50E+01 
GO:0004383 guanylate cyclase activity 6% 1.77E-22 15.83 3.34E-20 3.03E-21 2.19E-19 
GO:0004016 adenylate cyclase activity 6% 1.57E-20 14.72 2.97E-18 2.12E-19 1.95E-17 
GO:0019001 guanyl nucleotide binding 7% 1.48E-05 2.71 2.80E-03 1.12E-04 1.84E-02 
GO:0032561 guanyl ribonucleotide binding 7% 1.48E-05 2.71 2.80E-03 1.12E-04 1.84E-02 
GO:0005525 GTP binding 7% 2.65E-05 2.69 5.00E-03 1.93E-04 3.29E-02 
GO:0004690 cyclic nucleotide-dependent protein kinase activity 1% 4.99E-03 24.09 6.11E-01 3.10E-02 6.02E+00         
GO:0016849 phosphorus-oxygen lyase activity 6% 2.36E-21 14.58 4.46E-19 3.72E-20 2.93E-18 
GO:0004697 protein kinase C activity 2% 1.30E-05 16.06 2.45E-03 1.07E-04 1.61E-02 
GO:0035173 histone kinase activity 1% 1.40E-05 24.09 2.64E-03 1.10E-04 1.74E-02 
GO:0035174 histone serine kinase activity 1% 1.40E-05 24.09 2.64E-03 1.10E-04 1.74E-02 
GO:0035175 histone kinase activity (H3-S10 specific) 1% 8.11E-02 24.09 1.00E+00 3.67E-01 6.50E+01 
GO:0008353 RNA polymerase II carboxy-terminal domain kinase activity 1% 9.15E-05 17.21 1.72E-02 6.41E-04 1.14E-01 
GO:0005547 phosphatidylinositol-3,4,5-trisphosphate binding 1% 3.13E-02 10.32 9.98E-01 1.62E-01 3.26E+01 
GO:0004703 G-protein coupled receptor kinase activity 1% 8.11E-02 24.09 1.00E+00 3.67E-01 6.50E+01 
GO:0019955 cytokine binding 1% 8.11E-02 24.09 1.00E+00 3.67E-01 6.50E+01 
GO:0050321 tau-protein kinase activity 1% 8.11E-02 24.09 1.00E+00 3.67E-01 6.50E+01 
GO:0042169 SH2 domain binding 1% 8.11E-02 24.09 1.00E+00 3.67E-01 6.50E+01 
GO:0004711 ribosomal protein S6 kinase activity 1% 8.11E-02 24.09 1.00E+00 3.67E-01 6.50E+01 
GO:0016909 SAP kinase activity 1% 8.11E-02 24.09 1.00E+00 3.67E-01 6.50E+01 
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GO:0035612 AP-2 adaptor complex binding 1% 8.11E-02 24.09 1.00E+00 3.67E-01 6.50E+01 
GO:0036122 BMP binding 1% 8.11E-02 24.09 1.00E+00 3.67E-01 6.50E+01 
Table 6. Molecular function GO term analysis of the kinase sub-library indicates involvement in diverse regulatory processes. 
 
GO Term Enriched Term % p-value Fold Enrichment Bonferroni Benjamini FDR 
GO:0005737 cytoplasm 48.5 8.87E-75 4 9.41E-73 9.41E-73 9.96E-72 
GO:0031234 extrinsic component of cytoplasmic side of plasma membrane 10.4 6.10E-52 31 6.46E-50 3.23E-50 6.84E-49 
GO:0005634 nucleus 36.7 2.16E-28 3 2.29E-26 7.64E-27 2.43E-25 
GO:0008074 guanylate cyclase complex, soluble 6.0 2.13E-25 24 2.25E-23 5.63E-24 2.39E-22 
GO:0042995 cell projection 6.6 3.11E-15 9 3.30E-13 6.59E-14 3.49E-12 
GO:0005886 plasma membrane 14.8 1.27E-14 3 1.35E-12 2.26E-13 1.43E-11 
GO:0030424 axon 6.8 5.83E-13 6 6.18E-11 8.83E-12 6.54E-10 
GO:0043204 perikaryon 3.8 1.14E-11 13 1.20E-09 1.51E-10 1.28E-08 
GO:0030425 dendrite 3.8 1.47E-07 7 1.56E-05 1.74E-06 1.65E-04 
GO:0005929 cilium 2.7 5.13E-06 8 5.43E-04 5.44E-05 5.75E-03 
GO:0043025 neuronal cell body 4.4 5.56E-06 4 5.89E-04 5.36E-05 6.24E-03 
GO:0005815 microtubule organizing center 1.6 4.16E-04 9 4.32E-02 3.67E-03 4.66E-01 
GO:0031672 A band 1.1 6.59E-04 21 6.75E-02 5.36E-03 7.37E-01 
GO:0005813 centrosome 2.2 7.17E-04 5 7.32E-02 5.41E-03 8.01E-01 
GO:0005938 cell cortex 2.5 1.79E-03 4 1.73E-01 1.26E-02 2.00E+00 
GO:0044306 neuron projection terminus 0.8 4.34E-03 27 3.69E-01 2.84E-02 4.76E+00 
GO:0031430 M band 1.4 6.76E-03 6 5.13E-01 4.14E-02 7.33E+00 
GO:0005622 intracellular 5.5 1.15E-02 2 7.08E-01 6.60E-02 1.22E+01 
GO:0005694 chromosome 1.9 4.06E-02 3 9.88E-01 2.07E-01 3.72E+01 
GO:0031513 nonmotile primary cilium 1.6 4.51E-02 3 9.92E-01 2.17E-01 4.04E+01 
GO:0043005 neuron projection 1.6 5.23E-02 3 9.97E-01 2.37E-01 4.53E+01 
GO:0032133 chromosome passenger complex 0.5 5.41E-02 36 9.97E-01 2.35E-01 4.64E+01 
GO:0000780 condensed nuclear chromosome, centromeric region 0.5 5.41E-02 36 9.97E-01 2.35E-01 4.64E+01 
GO:0051233 spindle midzone 0.8 5.49E-02 8 9.97E-01 2.29E-01 4.70E+01 
GO:0000793 condensed chromosome 1.1 6.55E-02 4 9.99E-01 2.59E-01 5.32E+01 
GO:0005856 cytoskeleton 3.0 9.35E-02 2 1.00E+00 3.41E-01 6.68E+01 
GO:0016324 apical plasma membrane 1.4 9.42E-02 3 1.00E+00 3.32E-01 6.70E+01 
Table 7. Cellular component GO term analysis of the kinase sub-library reveals kinases are associated with many parts of the 
cell as expected.
 
 
3. Regulators of gpdh-1 expression include a large subset of the kinase library and are 
involved in diverse processes. 
 Initial screening of the kinase library identified 250 terms that either significantly 
downregulated (knockdown), reduced (diminisher), or upregulated (enhancer) a stress-related 
fluorescent reporter. This entire sub-list of genes-of-interest was analyzed to determine significant 
pathways or systematic differences from the sub-library analyses. As this was a sub-set of genes, 
we did not expect new terms to arise, but a few did likely due to the reduced total number of genes 
analyzed. This analysis indicated which pathways were not enriched in our hit set.  Most notably, 
the GO term determination of adult lifespan in the BP set was excluded (appendix, Table 27). 
There were several other terms excluded, including mitotic/meiotic nuclear division, 
thermosensory behavior, sensory processing, response to heat, and several different pathways 
related to heat, chemosensation, and MAPK activity. Analysis of CC indicated a few categories 
missing, such as spindle midzone and neuron projection, with no other noteworthy observations 
(appendix, Table 28). Analysis of MF indicated a few new terms at the lower threshold again, 
likely due to the reduced number of terms (Table 8). There were no changes in the KEGG pathways 
represented (Table 9). Overall, we saw the exclusion of many categories of terms enriched for BP 
and MF in pathways unrelated to the current experimental model. 
 
 
GO Term Enriched Term % p-value Fold Enrichment Bonferroni Benjamini FDR 
GO:0005524 ATP binding 99.5 0.00E+00 10 0.00E+00 0.00E+00 0.00E+00 
GO:0004672 protein kinase activity 98.6 0.00E+00 23 0.00E+00 0.00E+00 0.00E+00         
GO:0000166 nucleotide binding 74.2 1.88E-193 7 1.93E-191 4.83E-192 2.09E-190 
GO:0004674 protein serine/threonine kinase activity 63.6 3.29E-306 21 3.39E-304 1.70E-304 3.68E-303 
GO:0016301 kinase activity 56.4 1.49E-227 16 1.54E-225 5.13E-226 1.67E-224 
GO:0016740 transferase activity 48.8 1.52E-93 6 1.56E-91 2.61E-92 1.69E-90 
GO:0004713 protein tyrosine kinase activity 20 1.04E-93 23 1.07E-91 2.14E-92 1.16E-90 
GO:0046872 metal ion binding 18.6 8.63E-02 1 1.00E+00 2.83E-01 6.35E+01 
GO:0004715 non-membrane spanning protein tyrosine kinase activity 11.5 2.89E-51 22 2.97E-49 4.25E-50 3.22E-48 
GO:0005102 receptor binding 10.4 4.45E-35 15 4.59E-33 5.10E-34 4.97E-32 
GO:0004702 receptor signaling protein serine/threonine kinase activity 7.7 7.79E-36 24 8.03E-34 1.00E-34 8.70E-33 
GO:0005525 GTP binding 6.6 7.70E-06 3 7.93E-04 4.18E-05 8.60E-03 
GO:0004383 guanylate cyclase activity 6.3 3.31E-23 17 3.41E-21 3.41E-22 3.69E-20 
GO:0016849 phosphorus-oxygen lyase activity 6.3 4.46E-22 16 4.60E-20 4.18E-21 4.98E-19 
GO:0016829 lyase activity 6.3 8.37E-13 7 8.62E-11 6.16E-12 9.34E-10 
GO:0004016 adenylate cyclase activity 6.0 3.20E-21 16 3.30E-19 2.75E-20 3.57E-18 
GO:0004714 transmembrane receptor protein tyrosine kinase activity 3.8 3.01E-17 24 3.10E-15 2.38E-16 3.36E-14 
GO:0004707 MAP kinase activity 3.0 1.55E-12 22 1.60E-10 1.07E-11 1.73E-09 
GO:0005516 calmodulin binding 3.0 1.41E-06 7 1.45E-04 8.07E-06 1.57E-03 
GO:0004693 cyclin-dependent protein serine/threonine kinase activity 2.2 8.84E-10 26 9.10E-08 5.69E-09 9.86E-07 
GO:0004683 calmodulin-dependent protein kinase activity 1.9 2.05E-08 26 2.11E-06 1.24E-07 2.29E-05 
GO:0004697 protein kinase C activity 1.6 8.89E-06 17 9.16E-04 4.58E-05 9.92E-03 
GO:0009931 calcium-dependent protein serine/threonine kinase activity 1.4 1.03E-05 26 1.06E-03 5.03E-05 1.15E-02 
GO:0008353 RNA polymerase II carboxy-terminal domain kinase  1.4 6.76E-05 19 6.93E-03 3.16E-04 7.54E-02 
GO:0004709 MAP kinase kinase kinase activity 1.1 2.17E-04 26 2.21E-02 9.69E-04 2.41E-01 
GO:0004708 MAP kinase kinase activity 1.1 2.17E-04 26 2.21E-02 9.69E-04 2.41E-01 
GO:0035174 histone serine kinase activity 0.8 4.28E-03 26 3.57E-01 1.82E-02 4.67E+00 
GO:0031435 mitogen-activated protein kinase kinase kinase binding 0.8 1.35E-02 16 7.55E-01 5.46E-02 1.41E+01 
GO:0005547 phosphatidylinositol-3,4,5-trisphosphate binding 0.8 2.70E-02 11 9.41E-01 1.03E-01 2.64E+01 
GO:0004675 transmembrane receptor protein serine/threonine kinase  0.8 9.83E-02 6 1.00E+00 3.08E-01 6.85E+01 
GO:0035612 AP-2 adaptor complex binding 0.5 7.51E-02 26 1.00E+00 2.58E-01 5.82E+01 
GO:0008545 JUN kinase kinase activity 0.5 7.51E-02 26 1.00E+00 2.58E-01 5.82E+01 
GO:0036122 BMP binding 0.5 7.51E-02 26 1.00E+00 2.58E-01 5.82E+01 
GO:0035175 histone kinase activity (H3-S10 specific) 0.5 7.51E-02 26 1.00E+00 2.58E-01 5.82E+01 
GO:0004711 ribosomal protein S6 kinase activity 0.5 7.51E-02 26 1.00E+00 2.58E-01 5.82E+01 
GO:0004705 JUN kinase activity 0.5 7.51E-02 26 1.00E+00 2.58E-01 5.82E+01 
GO:0004712 protein serine/threonine/tyrosine kinase activity 0.5 7.51E-02 26 1.00E+00 2.58E-01 5.82E+01 
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GO:0050321 tau-protein kinase activity 0.5 7.51E-02 26 1.00E+00 2.58E-01 5.82E+01 
GO:0004703 G-protein coupled receptor kinase activity 0.5 7.51E-02 26 1.00E+00 2.58E-01 5.82E+01 
GO:0042169 SH2 domain binding 0.5 7.51E-02 26 1.00E+00 2.58E-01 5.82E+01 
GO:0004691 cAMP-dependent protein kinase activity 0.5 7.51E-02 26 1.00E+00 2.58E-01 5.82E+01 
Table 8. Molecular function GO term analysis of the regulators gene-set indicates a narrowing of the involved cellular process 
while maintaining broad involvement. 
 
KEGG Enriched Pathway % p-value Fold Enrichment Bonferroni Benjamini FDR 
cel04010 MAPK signaling pathway 6.8 5.92E-26 18 1.12E-24 1.12E-24 4.43E-23 
cel04012 ErbB signaling pathway 5.2 4.40E-22 24 8.36E-21 4.18E-21 3.30E-19 
cel04068 FoxO signaling pathway 4.7 1.10E-15 15 2.11E-14 6.99E-15 8.33E-13 
cel04931 Insulin resistance 3.6 2.77E-12 17 5.25E-11 1.31E-11 2.07E-09 
cel00230 Purine metabolism 3.6 2.50E-06 5 4.75E-05 7.92E-06 1.88E-03 
cel04150 mTOR signaling pathway 3.3 6.12E-12 19 1.16E-10 2.33E-11 4.59E-09 
cel04310 Wnt signaling pathway 2.7 3.73E-06 8 7.09E-05 1.01E-05 2.80E-03 
cel04340 Hedgehog signaling pathway 1.6 3.75E-06 22 7.13E-05 8.91E-06 2.81E-03 
cel04350 TGF-beta signaling pathway 1.4 6.89E-03 6 1.23E-01 1.30E-02 5.05E+00 
cel04140 Regulation of autophagy 1.1 5.16E-03 11 9.35E-02 1.09E-02 3.80E+00 
cel04320 Dorso-ventral axis formation 0.8 4.45E-02 9 5.79E-01 7.57E-02 2.89E+01 
Table 9. KEGG pathway analysis of the regulators gene-set indicated the involvement of many immune system-related pathways.
 
 
4. Genes that completely suppress constitutive gpdh-1 expression involve a reduced subset of 
GO terms. 
 We analyzed 120 genes whose knockdown resulted in reduced gpdh-1 expression by 
qualitative fluorescence analysis. Of those, MF analysis showed ~60% of kinases that knocked 
down green fluorescence expression have serine/threonine kinase activity (Table 10). Subsets of 
related enriched terms included receptor binding and transmembrane receptor activity. There was 
further enrichment for calcium/calmodulin activity with calcium-dependent protein kinase activity 
showing a 38-fold enrichment. The subset maintained enrichment for Cyclase activity, specifically 
guanylate cyclase activity, and adenylate cyclase activity, along with cyclin-dependent protein 
kinase activity, indicating involvement in nucleotide and cyclic nucleotide-binding. This subset 
resulted in a significant narrowing of terms, but MAP kinase activity and MAP kinase kinase kinase 
activity were maintained while JNK terms were not present. Compared to the fourteen 
uncategorized terms found in the original sub-library,  there were only two uncategorized terms, 
RNA polymerase II carboxy-terminal domain kinase activity, and phosphorus-oxygen lyase 
activity, indicating that this data set is far more focused on specific functional pathways.   
The cytoplasmic component GO term analysis shows kinases function in the cytoplasm 
and nucleus with some involvement in the plasma membrane (Table 11). There are terms related 
to the axon and the neuronal cell body. Of note, guanylate cyclase complex soluble was 
upregulated, which indicates coherence between CC and MF analyses.  In BP analysis, we see a 
significant narrowing (111 to 35) in the number of terms represented with intracellular signal 
transduction (21%), innate immune response (19%), and phosphorylation (59%) indicating the 
expected involvement in stress response and signal transduction (Table 12). There is significant 
enrichment for terms associated with defense responses to various stressors such as response to 
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osmotic stress, defense response to fungus and defense response to gram-positive/negative 
bacterium indicating that the genes knocked down are involved in mediating the stress response 
to multiple stressors. KEGG pathway analysis of Knockdown gene-set demonstrates significant 
enrichment for immune and apoptosis related pathways (Table 13).
 
 
GO Code Enriched Term % P-value Fold Enrichment Bonferroni Benjamini FDR 
GO:0004713 protein tyrosine kinase activity 25.0 1.75E-32 25 2.08E-30 1.10E-31 2.00E-29 
GO:0004715 non-membrane spanning protein tyrosine kinase activity 17.2 4.14E-24 31 4.92E-22 2.46E-23 4.74E-21 
GO:0005102 receptor binding 15.5 1.13E-09 7 1.34E-07 6.38E-09 1.29E-06 
GO:0005057 receptor signaling protein activity 6.9 3.77E-06 12 4.48E-04 2.04E-05 4.32E-03 
GO:0004702 receptor signaling protein serine/threonine kinase activity 6.0 2.94E-05 11 3.50E-03 1.52E-04 3.37E-02 
GO:0019199 transmembrane receptor protein kinase activity 4.3 5.01E-04 13 5.79E-02 2.13E-03 5.72E-01 
GO:0004714 transmembrane receptor protein tyrosine kinase activity 3.4 8.69E-04 20 9.83E-02 3.56E-03 9.91E-01         
GO:0005516 calmodulin binding 4.3 1.57E-03 10 1.70E-01 6.01E-03 1.78E+00 
GO:0004683 calmodulin-dependent protein kinase activity 3.4 3.27E-04 28 3.82E-02 1.44E-03 3.74E-01 
GO:0010857 calcium-dependent protein kinase activity 2.6 2.43E-03 38 2.51E-01 9.00E-03 2.75E+00 
GO:0009931 calcium-dependent protein serine/threonine kinase activity 2.6 2.43E-03 38 2.51E-01 9.00E-03 2.75E+00         
GO:0009975 cyclase activity 5.2 1.38E-04 12 1.62E-02 6.30E-04 1.58E-01 
GO:0004383 guanylate cyclase activity 5.2 8.09E-05 13 9.58E-03 4.01E-04 9.26E-02 
GO:0004016 adenylate cyclase activity 4.3 1.16E-03 11 1.29E-01 4.59E-03 1.32E+00 
GO:0097472 cyclin-dependent protein kinase activity 1.7 9.94E-02 19 1.00E+00 2.93E-01 6.99E+01 
GO:0004693 cyclin-dependent protein serine/threonine kinase activity 1.7 9.94E-02 19 1.00E+00 2.93E-01 6.99E+01         
GO:0004707 MAP kinase activity 2.6 1.19E-02 18 7.59E-01 4.23E-02 1.28E+01 
GO:0004709 MAP kinase kinase kinase activity 1.7 5.10E-02 38 9.98E-01 1.67E-01 4.51E+01         
GO:0008353 RNA polymerase II carboxy-terminal domain kinase activity 1.7 8.76E-02 22 1.00E+00 2.68E-01 6.50E+01 
GO:0016849 phosphorus-oxygen lyase activity 5.2 1.21E-04 12 1.43E-02 5.77E-04 1.39E-01 
Table 10. Molecular function GO term analysis of Knockdown gene-set indicates significant involvement of genes related to 
calcium signaling, receptor signaling, and MAPK activity. Enriched terms include tyrosine and serine/threonine kinase activity with 
receptor signaling.  This enrichment indicates these terms are involved in cellular signaling. Also, the concentration of genes in calcium 
and MAPK suggest that these kinases may be part of a broader signaling network to coordinate immune/stress responses.   
 
 
 
 
 
 
 
GO Code Enriched Term % p-value Fold Enrichment Bonferroni Benjamini FDR 
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GO:0031234 extrinsic component of cytoplasmic side of plasma membrane 15.5 5.90E-25 48 3.36E-23 3.36E-23 5.85E-22 
GO:0005737 cytoplasm 44.0 4.97E-20 4 2.83E-18 1.42E-18 4.92E-17 
GO:0005634 nucleus 39.7 2.54E-12 3 1.45E-10 4.82E-11 2.52E-09 
GO:0005886 plasma membrane 13.8 1.09E-04 3 6.21E-03 1.56E-03 1.08E-01 
GO:0008074 guanylate cyclase complex, soluble 4.3 1.55E-04 18 8.81E-03 1.77E-03 1.54E-01 
GO:0030424 axon 5.2 6.48E-03 5 3.10E-01 5.99E-02 6.24E+00 
GO:0043025 neuronal cell body 4.3 2.83E-02 4 8.05E-01 2.08E-01 2.48E+01 
GO:0031672 A band 1.7 5.70E-02 34 9.65E-01 3.42E-01 4.41E+01 
Table 11. Cellular component GO term analysis of Knockdown gene-set indicates expected involvement in primary cellular 
components. 
GO Code Enriched Term % p-value Fold Enrichment Bonferroni Benjamini FDR 
GO:0006468 protein phosphorylation 96.6 1.71E-160 26 3.59E-158 
3.59E-
158 
2.16E-
157 
GO:0016310 phosphorylation 59.5 1.56E-75 20 3.28E-73 1.64E-73 1.97E-72 
GO:0018105 peptidyl-serine phosphorylation 30.2 3.37E-40 27 7.08E-38 2.36E-38 4.26E-37 
GO:0008360 regulation of cell shape 20.7 4.88E-26 25 1.02E-23 2.56E-24 6.16E-23 
GO:0038083 peptidyl-tyrosine autophosphorylation 15.5 6.98E-24 42 1.47E-21 2.93E-22 8.82E-21 
GO:0007169 transmembrane receptor protein tyrosine kinase signaling pathway 16.4 8.32E-24 36 1.75E-21 2.91E-22 1.05E-20 
GO:0035556 intracellular signal transduction 20.7 3.00E-21 16 6.30E-19 9.00E-20 3.79E-18 
GO:0030154 cell differentiation 18.1 4.42E-16 12 9.33E-14 1.17E-14 5.66E-13 
GO:0042127 regulation of cell proliferation 14.7 6.04E-13 12 1.27E-10 1.41E-11 7.63E-10 
GO:0045087 innate immune response 19.0 3.15E-12 7 6.62E-10 6.62E-11 3.98E-09 
GO:0018108 peptidyl-tyrosine phosphorylation 9.5 1.32E-11 25 2.76E-09 2.51E-10 1.66E-08 
GO:0046777 protein autophosphorylation 6.0 8.82E-09 42 1.85E-06 1.54E-07 1.11E-05 
GO:0006182 cGMP biosynthetic process 5.2 2.13E-05 17 4.46E-03 3.44E-04 2.69E-02 
GO:0009190 cyclic nucleotide biosynthetic process 5.2 3.22E-05 16 6.73E-03 4.82E-04 4.06E-02 
GO:0000165 MAPK cascade 4.3 6.72E-05 22 1.40E-02 9.41E-04 8.49E-02 
GO:0050832 defense response to fungus 3.4 2.02E-03 16 3.47E-01 2.63E-02 2.53E+00 
GO:0007275 multicellular organism development 10.3 2.18E-03 3 3.68E-01 2.66E-02 2.72E+00 
GO:0006970 response to osmotic stress 2.6 4.07E-03 30 5.76E-01 4.65E-02 5.03E+00 
GO:0010172 embryonic body morphogenesis 3.4 5.18E-03 11 6.64E-01 5.58E-02 6.35E+00 
GO:0018107 peptidyl-threonine phosphorylation 2.6 8.03E-03 22 8.16E-01 8.12E-02 9.68E+00 
GO:0007049 cell cycle 5.2 1.21E-02 4 9.23E-01 1.15E-01 1.43E+01 
GO:0045167 asymmetric protein localization involved in cell fate determination 2.6 1.61E-02 15 9.67E-01 1.44E-01 1.86E+01 
GO:0007163 establishment or maintenance of cell polarity 2.6 1.77E-02 14 9.77E-01 1.51E-01 2.02E+01 
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GO:0040018 positive regulation of multicellular organism growth 7.8 2.40E-02 3 9.94E-01 1.92E-01 2.65E+01 
GO:0023014 signal transduction by protein phosphorylation 2.6 2.85E-02 11 9.98E-01 2.16E-01 3.06E+01 
GO:0038066 p38MAPK cascade 1.7 2.91E-02 67 9.98E-01 2.12E-01 3.12E+01 
GO:0009790 embryo development 2.6 3.05E-02 11 9.99E-01 2.14E-01 3.24E+01 
GO:0000186 activation of MAPKK activity 1.7 3.87E-02 51 1.00E+00 2.56E-01 3.92E+01 
GO:0051301 cell division 4.3 4.56E-02 4 1.00E+00 2.87E-01 4.46E+01 
GO:1902097 positive regulation of transcription from RNA polymerase II promoter  1.7 4.81E-02 40 1.00E+00 2.92E-01 4.63E+01 
GO:0050829 defense response to Gram-negative bacterium 3.4 4.94E-02 5 1.00E+00 2.90E-01 4.73E+01 
GO:1903616 MAPK cascade involved in axon regeneration 1.7 5.74E-02 34 1.00E+00 3.22E-01 5.26E+01 
GO:0050830 defense response to Gram-positive bacterium 2.6 5.84E-02 8 1.00E+00 3.18E-01 5.32E+01 
GO:0050807 regulation of synapse organization 1.7 7.58E-02 25 1.00E+00 3.86E-01 6.31E+01 
GO:0051782 negative regulation of cell division 1.7 9.39E-02 20 1.00E+00 4.46E-01 7.12E+01 
Table 12. Biological process GO term analysis of Knockdown gene-set indicates expected involvement in stress response and 
development.  Of note, there are many enriched terms associated with the immune response to stress and pathogens  
 
 
KEGG Enriched Pathway % p-value Fold Enrichment Bonferroni Benjamini FDR 
cel04010 MAPK signaling pathway 6.0 1.34E-06 17 2.01E-05 2.01E-05 9.33E-04 
cel04068 FoxO signaling pathway 4.3 2.25E-04 15 3.38E-03 1.69E-03 1.57E-01 
cel04150 mTOR signaling pathway 3.4 7.31E-04 21 1.09E-02 3.65E-03 5.07E-01 
cel04012 ErbB signaling pathway 2.6 2.06E-02 13 2.68E-01 7.50E-02 1.35E+01 
cel00230 Purine metabolism 3.4 2.95E-02 6 3.62E-01 8.59E-02 1.88E+01 
cel04310 Wnt signaling pathway 2.6 5.35E-02 8 5.61E-01 1.28E-01 3.17E+01 
cel04340 Hedgehog signaling pathway 1.7 7.67E-02 24 6.98E-01 1.57E-01 4.26E+01 
Table 13. KEGG pathway analysis of Knockdown gene-set demonstrates significant enrichment for immune-related and 
apoptosis-related pathways. 
  
 
 
5. GO term analysis of diminishers of gpdh-1 indicates similar associations to the knockdown 
gene-set pathways further implicating immune function. 
 Analysis of MF GO terms indicates enrichment patterns similar to the knockdown and 
regulators gene-sets (Table 14). There is an enrichment of terms related to receptor activity and 
serine/threonine kinase activity confirming similar functionality to that of the knockdown set. 
Also, this set maintained enrichment for nucleotide-binding related terms with the addition of 
GTP binding. Interestingly, there is significant enrichment for immune signaling through MAP 
kinase activity and mitogen-activated protein kinase kinase kinase binding, which further 
validates the importance of the immune system. The few uncategorized terms present include 
histone kinase activity and histone serine kinase activity, indicating possible epigenetic 
regulation. GO term analysis of CC revealed similar terms to the knockdown set (Table 15). GO 
term analysis of BP terms revealed similar patterns with a few noteworthy findings including, 
Signal transduction, intracellular signal transduction, Wnt signaling pathway, MAPK cascade, 
JNK cascade, and Ras protein signal transduction (Table 16). The enrichment of these terms, in 
addition to the knockdown set terms, indicates these immune pathways are wholly involved in 
regulating gpdh-1 synthesis with significant redundancy. KEGG pathway analysis reveals a 
profound enrichment for immune pathways (Table 17).   
 
 
 
GO Term Enriched Term % p-value Fold Enrichment Bonferroni Benjamini FDR 
GO:0004674 protein serine/threonine kinase activity 67.3 3.57E-72 19 4.25E-70 2.65E-71 4.09E-69 
GO:0004713 protein tyrosine kinase activity 20.4 5.04E-20 20 5.99E-18 3.15E-19 5.77E-17 
GO:0004871 signal transducer activity 20.4 1.69E-02 2 8.69E-01 6.34E-02 1.78E+01 
GO:0004702 receptor signaling protein serine/threonine kinase activity 10.2 1.64E-09 19 1.95E-07 8.86E-09 1.88E-06 
GO:0005057 receptor signaling protein activity 10.2 3.53E-09 18 4.20E-07 1.83E-08 4.04E-06 
GO:0019199 transmembrane receptor protein kinase activity 9.2 5.93E-10 28 7.06E-08 3.36E-09 6.80E-07 
GO:0005102 receptor binding 9.2 2.01E-03 4 2.13E-01 8.24E-03 2.28E+00 
GO:0004714 transmembrane receptor protein tyrosine kinase activity 8.2 9.75E-11 48 1.16E-08 5.80E-10 1.12E-07 
GO:0005525 GTP binding 7.1 3.16E-02 3 9.78E-01 1.10E-01 3.08E+01 
GO:0032561 guanyl ribonucleotide binding 7.1 3.62E-02 3 9.88E-01 1.21E-01 3.44E+01 
GO:0019001 guanyl nucleotide binding 7.1 3.62E-02 3 9.88E-01 1.21E-01 3.44E+01 
GO:0004383 guanylate cyclase activity 6.1 3.73E-05 15 4.42E-03 1.85E-04 4.27E-02 
GO:0004016 adenylate cyclase activity 6.1 4.29E-05 15 5.09E-03 2.04E-04 4.92E-02 
GO:0016849 phosphorus-oxygen lyase activity 6.1 5.61E-05 14 6.66E-03 2.57E-04 6.43E-02 
GO:0009975 cyclase activity 6.1 6.38E-05 14 7.57E-03 2.81E-04 7.31E-02 
GO:0004715 non-membrane spanning protein tyrosine kinase activity 6.1 1.94E-04 11 2.28E-02 8.23E-04 2.22E-01 
GO:0004707 MAP kinase activity 3.1 8.73E-03 21 6.48E-01 3.42E-02 9.56E+00 
GO:0035612 AP-2 adaptor complex binding 2.0 2.20E-02 89 9.29E-01 7.94E-02 2.25E+01 
GO:0004703 G-protein coupled receptor kinase activity 2.0 2.20E-02 89 9.29E-01 7.94E-02 2.25E+01 
GO:0031435 mitogen-activated protein kinase kinase kinase binding 2.0 5.41E-02 36 9.99E-01 1.72E-01 4.71E+01 
GO:0035173 histone kinase activity 2.0 5.41E-02 36 9.99E-01 1.72E-01 4.71E+01 
GO:0035174 histone serine kinase activity 2.0 5.41E-02 36 9.99E-01 1.72E-01 4.71E+01 
GO:0097472 cyclin-dependent protein kinase activity 2.0 8.52E-02 22 1.00E+00 2.55E-01 6.40E+01 
GO:0004693 cyclin-dependent protein serine/threonine kinase activity 2.0 8.52E-02 22 1.00E+00 2.55E-01 6.40E+01 
Table 14. Molecular function GO term analysis of diminisher gene-set terms indicates enrichment for receptor signaling, 
immune function, and nucleotide-binding. Enriched terms include MAP kinase activity and histone kinase activity indicating 
involvement in immune responses and epigenetic regulation of gene expression. 
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GO Term Enriched Term % p-value Fold Enrichment Bonferroni Benjamini FDR 
GO:0005737 cytoplasm 49.0 1.14E-20 4 7.41E-19 7.41E-19 1.16E-17 
GO:0005634 nucleus 33.7 1.32E-06 2 8.56E-05 2.85E-05 1.34E-03 
GO:0005886 plasma membrane 17.3 4.83E-06 4 3.14E-04 6.28E-05 4.92E-03 
GO:0042995 cell projection 9.2 7.18E-07 12 4.67E-05 2.33E-05 7.32E-04 
GO:0030424 axon 7.1 5.63E-04 7 3.59E-02 4.56E-03 5.72E-01 
GO:0008074 guanylate cyclase complex, soluble 6.1 3.71E-06 25 2.41E-04 6.02E-05 3.78E-03 
GO:0043204 perikaryon 6.1 7.62E-06 21 4.95E-04 8.25E-05 7.76E-03 
GO:0031234 extrinsic component of cytoplasmic side of plasma membrane 6.1 1.59E-05 18 1.03E-03 1.48E-04 1.62E-02 
GO:0030425 dendrite 5.1 2.38E-03 9 1.44E-01 1.71E-02 2.40E+00 
GO:0043025 neuronal cell body 4.1 7.98E-02 4 9.96E-01 3.03E-01 5.72E+01 
GO:0005929 cilium 3.1 4.78E-02 8 9.59E-01 2.33E-01 3.93E+01 
GO:0005813 centrosome 3.1 6.09E-02 7 9.83E-01 2.70E-01 4.73E+01 
GO:0016324 apical plasma membrane 3.1 7.72E-02 6 9.95E-01 3.11E-01 5.59E+01 
GO:0032133 chromosome passenger complex 2.0 1.45E-02 135 6.14E-01 9.08E-02 1.39E+01 
GO:0000780 condensed nuclear chromosome, centromeric region 2.0 1.45E-02 135 6.14E-01 9.08E-02 1.39E+01 
GO:0031616 spindle pole centrosome 2.0 2.89E-02 68 8.51E-01 1.59E-01 2.58E+01 
GO:0051233 spindle midzone 2.0 9.75E-02 19 9.99E-01 3.41E-01 6.49E+01 
Table 15. Cellular component GO term analysis of the diminisher gene-set indicates involvement in most major cellular 
components with distribution in the nucleus and cytoplasm. Kinases are essential signaling molecules to cellular processes, 
particularly growth and differentiation. 
 
 
GO Term Enriched Term % p-value Fold Enrichment Bonferroni Benjamini FDR 
GO:0016310 phosphorylation 53.1 1.54E-52 18 3.71E-50 1.85E-50 1.99E-49 
GO:0018105 peptidyl-serine phosphorylation 32.7 1.07E-37 29 2.58E-35 8.59E-36 1.38E-34 
GO:0008360 regulation of cell shape 23.5 3.89E-26 28 9.38E-24 2.35E-24 5.03E-23 
GO:0018108 peptidyl-tyrosine phosphorylation 15.3 3.98E-19 40 9.59E-17 1.92E-17 5.14E-16 
GO:0035556 intracellular signal transduction 13.3 5.13E-09 10 1.24E-06 2.06E-07 6.62E-06 
GO:0007165 signal transduction 11.2 2.59E-03 3 4.65E-01 3.61E-02 3.29E+00 
GO:0016055 Wnt signaling pathway 9.2 7.05E-09 21 1.70E-06 2.43E-07 9.10E-06 
GO:0007169 transmembrane receptor protein tyrosine kinase signaling 9.2 1.14E-08 20 2.75E-06 3.43E-07 1.47E-05 
GO:0007275 multicellular organism development 9.2 2.05E-02 3 9.93E-01 2.03E-01 2.35E+01 
GO:0030154 cell differentiation 8.2 7.07E-04 5 1.57E-01 1.21E-02 9.09E-01 
GO:0045087 innate immune response 8.2 1.66E-02 3 9.83E-01 1.75E-01 1.95E+01 
GO:0006182 cGMP biosynthetic process 6.1 9.70E-06 20 2.33E-03 2.34E-04 1.25E-02 
GO:0009190 cyclic nucleotide biosynthetic process 6.1 1.47E-05 19 3.54E-03 3.22E-04 1.90E-02 
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GO:0038083 peptidyl-tyrosine autophosphorylation 6.1 2.73E-05 17 6.55E-03 5.48E-04 3.52E-02 
GO:0042127 regulation of cell proliferation 6.1 7.04E-03 5 8.18E-01 8.57E-02 8.72E+00 
GO:0018107 peptidyl-threonine phosphorylation 5.1 4.27E-06 42 1.03E-03 1.14E-04 5.52E-03 
GO:0007049 cell cycle 5.1 2.95E-02 4 9.99E-01 2.51E-01 3.21E+01 
GO:0046777 protein autophosphorylation 4.1 3.52E-04 28 8.13E-02 6.50E-03 4.53E-01 
GO:0000165 MAPK cascade 4.1 8.83E-04 21 1.92E-01 1.41E-02 1.13E+00 
GO:0023014 signal transduction by protein phosphorylation 4.1 1.42E-03 18 2.91E-01 2.12E-02 1.82E+00 
GO:0006897 endocytosis 4.1 7.00E-03 10 8.16E-01 8.97E-02 8.67E+00 
GO:0006935 chemotaxis 4.1 1.31E-02 8 9.58E-01 1.47E-01 1.56E+01 
GO:0007399 nervous system development 4.1 2.91E-02 6 9.99E-01 2.57E-01 3.17E+01 
GO:0043652 engulfment of apoptotic cell 4.1 3.82E-02 5 1.00E+00 3.03E-01 3.95E+01 
GO:0016477 cell migration 4.1 8.50E-02 4 1.00E+00 5.10E-01 6.82E+01 
GO:0010628 positive regulation of gene expression 3.1 5.41E-02 8 1.00E+00 3.91E-01 5.12E+01 
GO:0051321 meiotic cell cycle 3.1 9.19E-02 6 1.00E+00 5.16E-01 7.12E+01 
GO:0035404 histone-serine phosphorylation 2.0 2.48E-02 79 9.98E-01 2.32E-01 2.77E+01 
GO:2000369 regulation of clathrin-mediated endocytosis 2.0 2.48E-02 79 9.98E-01 2.32E-01 2.77E+01 
GO:0007254 JNK cascade 2.0 2.48E-02 79 9.98E-01 2.32E-01 2.77E+01 
GO:0060069 Wnt signaling pathway, regulating spindle positioning 2.0 6.48E-02 30 1.00E+00 4.38E-01 5.79E+01 
GO:0007265 Ras protein signal transduction 2.0 7.27E-02 26 1.00E+00 4.66E-01 6.23E+01 
GO:0000278 mitotic cell cycle 2.0 8.81E-02 22 1.00E+00 5.12E-01 6.96E+01 
GO:0007608 sensory perception of smell 2.0 9.57E-02 20 1.00E+00 5.20E-01 7.27E+01 
Table 16. Biological process GO term analysis of the diminisher gene-set indicates immune regulation and cell growth and 
differentiation processes as expected. This gene set is involved with immune signaling, cell migration, cell growth and differentiation, 
and apoptotic cell engulfment. 
KEGG Enriched Pathway % p-value Fold Enrichment Bonferroni Benjamini FDR 
cel04012 ErbB signaling pathway 10.2 1.42E-13 42 2.13E-12 2.13E-12 9.86E-11 
cel04010 MAPK signaling pathway 7.1 1.34E-06 17 2.01E-05 1.01E-05 9.33E-04 
cel04931 Insulin resistance 5.1 5.70E-05 21 8.55E-04 2.85E-04 3.96E-02 
cel04068 FoxO signaling pathway 5.1 2.25E-04 15 3.38E-03 8.45E-04 1.57E-01 
cel04310 Wnt signaling pathway 5.1 4.40E-04 13 6.58E-03 1.32E-03 3.06E-01 
cel04340 Hedgehog signaling pathway 3.1 2.64E-03 36 3.89E-02 6.59E-03 1.82E+00 
cel04150 mTOR signaling pathway 3.1 1.42E-02 15 1.93E-01 3.02E-02 9.46E+00 
cel04350 TGF-beta signaling pathway 3.1 2.06E-02 13 2.68E-01 3.82E-02 1.35E+01 
cel04320 Dorso-ventral axis formation 2.0 9.50E-02 19 7.76E-01 1.53E-01 5.00E+01 
Table 17. KEGG pathway analysis of the diminisher gene-set indicated enrichment for essential signaling pathways, including 
energy homeostasis, longevity genes, stress response, and cell differentiation. 
 
 
6. GO term analysis of enhancer gene-set indicates signaling functionality and involvement 
in the cell cycle. 
 The enhancer gene-set was much smaller than the other sets with only 29 terms. The 
Analysis of BP terms indicated very few terms (15) terms including intracellular signal 
transduction and other related signaling terms as wells as several relevant to cell fate 
determination: meiotic cell cycle, cell differentiation, and regulation of cell cycle (Table 18). GO 
term analysis of CC indicated nothing novel (Table 19). GO term analysis of MF showed 
involvement in signaling pathways, cyclase activity, and phosphorous-oxygen lyase activity (Table 
20). These terms indicate participation in fundamental processes but, the collection of terms gives 
little indication of a specific pathway or process of interest.  Analysis of KEGG pathways was 
reduced to only one term, purine metabolism, which is quite a broad pathway and is expected from 
the enrichment for terms associated with cyclase activities (Table 21). The exclusion of all other 
pathways is unusual in that the other gene-sets appear more specific in light of their exclusion in 
this set, but this does not provide any additional information.   
  
 
 
 
GO Term Enriched Term % p-value Fold Enrichment Bonferroni Benjamini FDR 
GO:0016310 phosphorylation 50.0 1.70E-13 17 1.82E-11 9.11E-12 1.91E-10 
GO:0018105 peptidyl-serine phosphorylation 21.4 1.11E-05 19 1.19E-03 2.98E-04 1.25E-02 
GO:0023014 signal transduction by protein phosphorylation 17.9 3.90E-07 77 4.18E-05 1.39E-05 4.39E-04 
GO:0035556 intracellular signal transduction 17.9 4.10E-04 13 4.29E-02 8.73E-03 4.60E-01 
GO:0006182 cGMP biosynthetic process 10.7 2.95E-03 36 2.71E-01 5.13E-02 3.26E+00 
GO:0009190 cyclic nucleotide biosynthetic process 10.7 3.47E-03 33 3.10E-01 5.17E-02 3.83E+00 
GO:0007169 transmembrane receptor protein tyrosine kinase signaling 10.7 6.65E-03 24 5.10E-01 8.54E-02 7.23E+00 
GO:0051321 meiotic cell cycle 10.7 8.73E-03 20 6.09E-01 9.90E-02 9.39E+00 
GO:0008360 regulation of cell shape 10.7 2.15E-02 13 9.03E-01 2.08E-01 2.17E+01 
GO:0030154 cell differentiation 10.7 6.37E-02 7 9.99E-01 4.44E-01 5.23E+01 
GO:0051726 regulation of cell cycle 7.1 5.65E-02 33 9.98E-01 4.32E-01 4.80E+01 
GO:0007635 chemosensory behavior 7.1 9.32E-02 20 1.00E+00 5.53E-01 6.67E+01 
GO:0038083 peptidyl-tyrosine autophosphorylation 7.1 9.53E-02 19 1.00E+00 5.35E-01 6.76E+01 
GO:0018108 peptidyl-tyrosine phosphorylation 7.1 9.95E-02 18 1.00E+00 5.27E-01 6.92E+01 
Table 18. Biological process GO term analysis of the enhancer gene-set indicates enrichment for cell growth and differentiation 
as well as regulation of apoptosis. 
 
GO Term Enriched Term % p-value Fold Enrichment Bonferroni Benjamini FDR 
GO:0005737 cytoplasm 35.7 1.84E-03 3 4.16E-02 4.16E-02 1.45E+00 
GO:0005634 nucleus 28.6 7.34E-02 2 8.27E-01 4.43E-01 4.54E+01 
GO:0008074 guanylate cyclase complex, soluble 10.7 1.99E-03 43 4.47E-02 2.26E-02 1.57E+00 
GO:0031234 extrinsic component of cytoplasmic side of plasma membrane 7.1 8.54E-02 22 8.72E-01 4.01E-01 5.07E+01 
GO:0005929 cilium 7.1 9.28E-02 20 8.93E-01 3.61E-01 5.38E+01 
Table 19. Cellular component GO term analysis the enhancer gene-set indicates only a few terms including guanylate cyclase 
complex, soluble confirming expected kinase function. 
 
GO Term Enriched Term % p-value Fold Enrichment Bonferroni Benjamini FDR 
GO:0004674 protein serine/threonine kinase activity 57.1 1.94E-15 16 1.13E-13 7.11E-15 1.89E-12 
GO:0004702 receptor signaling protein serine/threonine kinase activity 17.9 1.16E-05 33 6.97E-04 3.67E-05 1.16E-02 
GO:0005057 receptor signaling protein activity 17.9 1.61E-05 31 9.68E-04 4.84E-05 1.62E-02 
GO:0004713 protein tyrosine kinase activity 14.3 2.40E-03 14 1.34E-01 6.53E-03 2.38E+00 
GO:0019001 guanyl nucleotide binding 14.3 2.99E-02 6 8.39E-01 6.31E-02 2.63E+01 
GO:0032561 guanyl ribonucleotide binding 14.3 2.99E-02 6 8.39E-01 6.31E-02 2.63E+01 
GO:0004693 cyclin-dependent protein serine/threonine kinase activity 10.7 2.53E-04 117 1.51E-02 7.22E-04 2.53E-01 
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GO:0097472 cyclin-dependent protein kinase activity 10.7 2.53E-04 117 1.51E-02 7.22E-04 2.53E-01 
GO:0004383 guanylate cyclase activity 10.7 5.10E-03 27 2.64E-01 1.33E-02 5.00E+00 
GO:0004016 adenylate cyclase activity 10.7 5.39E-03 26 2.77E-01 1.34E-02 5.27E+00 
GO:0016849 phosphorus-oxygen lyase activity 10.7 5.99E-03 25 3.03E-01 1.43E-02 5.85E+00 
GO:0009975 cyclase activity 10.7 6.31E-03 24 3.16E-01 1.45E-02 6.14E+00 
GO:0008353 RNA polymerase II carboxy-terminal domain kinase activity 7.1 2.14E-02 89 7.26E-01 4.69E-02 1.95E+01 
Table 20. Molecular function GO term analysis of enhancer gene-set molecular function illustrates the involvement of expected 
kinase functions as well as significant enrichment for cyclase activity. 
 
Term Enriched Pathway % p-value Fold Enrichment Bonferroni Benjamini FDR 
cel00230 Purine metabolism 7.1 9.98E-02 15 4.68E-01 4.68E-01 3.95E+01 
Table 21. KEGG pathway analysis of the enhancer gene-set indicated purine metabolism as the only enriched pathway. 
 
7. Web-based gene set enrichment analysis tool (WEBGESTALT) over-representation analysis confirmed 
DAVID functional annotation findings. 
 We analyzed gene-sets through an over-representation analysis (ORA) using a web-based gene set enrichment 
analysis tool (WEBGESTALT). The initial results indicated agreement with the results of the DAVID analysis in 
terms of the representation of GO terms associated with MF (Figure 7), BP (Figure 8), and CC (Figure 9). These 
results indicated divergent counts of genes represented correlating to total counts but also showed similar relative 
representation except for a few terms, which differed slightly. These results confirm our DAVID findings and 
corroborate our assertion that the selected library is composed of kinases that impact many cellular processes.  
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Figure 7. Molecular function GO term counts differ between gene-sets. However, the relative proportions of genes in each set 
did not significantly vary. 
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Figure 8. Biological process GO term counts differ between gene-sets, with little variation in the relative proportion of genes. 
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Figure 9. Cellular component GO term analysis of gene-sets indicates variance in the counts of terms in each category with little 
variation in the relative proportion of genes. 
 
 WEBGESTALT was used to perform a modified gene-set enrichment analysis utilizing set values for gene-set (1 enhancer, -1 
knockdown, and -0.5 diminisher), which yielded no findings of interest (data not shown). Network analysis of the knockdown gene-set 
indicated an interconnected sub-network among many genes (Figure 10), and GO term network analysis illustrated the interdependent 
role these kinases play in diverse cellular processes (Figure 11). The overrepresentation of highlighted terms was quantified (Figure 12).   
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Figure 10. Network analysis of knockdown gene-set kinases illustrates the density of interconnectedness. The frequency of the 
connections between these kinases indicates they are involved in related pathways and processes which validate their shared function. 
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Figure 11. Network analysis of knockdown gene-set GO terms confirm our library content and illustrate the broader 
involvement kinases have in cellular processes. 
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Figure 12. Network analysis of knockdown gene-set GO terms reveals the involvement of the kinases in many fundamental 
molecular processes. These results corroborate the results found in Tables 4-5.  
 
 Knockdown gene set ORA GO term enrichment (Figure 13) confirmed the results of DAVID analysis in that the gene-set was 
composed of kinases. Analysis of the KEGG and Reactome pathway enrichment indicates involvement in immune function and 
endoplasmic reticulum (ER) stress (Figure 14, Table 22). Among the significantly over-represented terms were p38MAPK events, 
activated TAK1 mediates p38 MAPK activation, and MAPK signaling pathway indicating that the stress-responsive MAPK pathway is 
a significant player in the regulation of gpdh-1 synthesis and reflects a high degree of cellular stress. VEGF and VEGFA-VEGF2R are 
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typically involved in angiogenic processes in response to local metabolite stress, including hypoxia. The VP611 strain has profound 
hypoxia resistance; thus, it is interesting that the inhibition of a hypoxia-related pathway would interfere with an osmotic stress defense 
enzyme. Repression of the canonical genes activating the FoxO signaling pathway did not affect gpdh-1 expression, but the other 
pathways represented here may also serve as activators of the FoxO pathway.   
 
 
Figure 13. Summary of GO term counts within the knockdown gene-set confirm kinase functionality and reveal involvement in 
diverse cellular processes. These results provide a concise graphical representation of DAVID analysis results. 
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Figure 14. KEGG and Reactome analysis of knockdown gene-set reveal involvement in immune function (MAPK) and ER stress 
(ERK). The significant overrepresentation of p38MAPK events, activated TAK1 mediates p38 MAPK activation, and MAPK signaling 
pathway indicates that the stress-responsive MAPK pathway is a significant player in the regulation of gpdh-1 synthesis and reflects a 
high degree of cellular stress.  VEGF and VEGFA-VEGF2R are typically involved in angiogenic processes in response to metabolite 
stress, including hypoxia.  Given this mutant’s profound hypoxia resistance, it is not surprising to find these terms enriched. Many of 
the canonical components of the FoxO signaling pathway were not found in this gene-set, making this an unexpected finding.  
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Pathway Description Size Expect Ratio p-value FDR 
cel04010 MAPK signaling pathway 77 0.62589 17.58 1.10E-11 1.13E-08 
R-CEL-194138 Signaling by VEGF 26 0.21134 33.12 8.05E-10 2.76E-07 
R-CEL-4420097 VEGFA-VEGFR2 Pathway 26 0.21134 33.12 8.05E-10 2.76E-07 
R-CEL-450302 activated TAK1 mediates p38 MAPK activation 9 0.07316 54.68 4.60E-07 0.0001183 
R-CEL-171007 p38MAPK events 4 0.03251 92.27 1.9835E-06 0.0004082 
cel04068 FoxO signaling pathway 59 0.47958 12.51 6.471E-06 0.0011098 
R-CEL-167044 Signaling to RAS 7 0.0569 52.73 1.7063E-05 0.001752 
R-CEL-187687 Signaling to ERKs 7 0.0569 52.73 1.7063E-05 0.001752 
R-CEL-453274 Mitotic G2-G2/M phases 21 0.1707 23.43 2.0357E-05 0.001752 
R-CEL-69273 Cyclin A/B1/B2 associated events during G2/M transition 21 0.1707 23.43 2.0357E-05 0.001752 
Table 22. KEGG and Reactome analysis of knockdown gene-set reveal involvement in immune function (MAPK) and ER stress 
(ERK). This table shows the data for figure 16. 
8. KEGG and Reactome pathway analys6s of regulators of gpdh-1 indicate involvement in many immune pathways. 
 KEGG and Reactome analysis of the regulator’s gene-set indicated the involvement of several toll-like receptors (TLRs) and 
several immune-related signaling pathways, including the MAPK signaling pathway, signaling by VEGF, VEGFA-VEGFR2 pathway, 
and ErbB signaling pathway (Figure 15). The involvement of several TLRs may be the signaling mechanism that activates many of 
the other pathways. ErbB signaling is upstream of both VEGF and MAPK pathways and is the most overrepresented term in this 
analysis. The immune system is involved in many if not all, cellular stress responses and the TLRs have diverse roles in danger 
sensing. Thus, it should come as no surprise that regulators of gpdh-1, an osmo-protective gene, function to mediate the immune 
response as well. 
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Figure 15. KEGG and Reactome of the regulators gene-set indicate enrichment for several Toll-Like Receptor (TLR) cascades, 
indicating significant involvement in immune signaling. The upregulation of TLR 3,4,9 and 10 suggests that several different 
pathogen response pathways are involved in the activation of gpdh-1.  The upregulation of the MAPK signaling pathway and VEGFA-
VEFGFR2 Pathway indicates the regulation of the immune system function.  
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9. KEGG and Reactome analysis of negative regulators of gpdh-1 (knockdown and 
diminisher gene-set) indicate immune system involvement. 
 KEGG and Reactome analysis of negative regulators of gpdh-1 (knockdown and 
diminisher gene-set) indicated that many of the terms represented in the analysis of the regulators 
gene-set resulted from the negative gene-set (Figure 16).  This comparison allowed for a closer 
examination of the interaction between the knockdown and diminisher gene-sets, and we see an 
even more significant enhancement of MAPK signaling pathway than was found in just the 
knockdown gene-set. This enrichment indicates that some of the genes whose knockdown 
slightly reduced gpdh-1 expression were involved in the same pathways, which resulted in a 
complete knockdown. Interestingly, the exclusion of the enhancers did not result in the removal 
or addition of any terms but did cause some reshuffling of terms resulting in VEGF related 
signaling being the most overrepresented term though not by a significant margin.   
 
 
 
 
Figure 16. KEGG and Reactome analysis of negative regulators (knockdown and diminisher gene-sets) indicate immune system 
involvement with an enhanced role played by VEGFA-VEGFR2 Pathway and signaling by VEGF. This analysis suggests an 
increased role for the MAPK signaling pathway, which indicates a more significant role than was demonstrated by the knockdown gene-
set.  
 
10. KEGG and Reactome pathway analysis of the diminisher gene-set showed upregulation of TLR signaling. 
 KEGG and Reactome pathway analysis of the diminisher gene-set indicated significant enrichment for TLR terms and the 
ErbB signaling pathway (Figure 17). Examining the terms represented here, we can imagine that the knockdown of any one of these 
receptors may disrupt homeostasis. Still, due to the significant redundancy among these receptors, the knockdown of any particular 
one may cause only a slight disruption.  This minor disruption in our case only caused a reduction in the degree of gpdh-1 expression. 
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The ErrbB signaling pathway functions to regulate many other pathways, including MAPK, JNK, Calcium signaling, PI3K/Akt 
signaling to mTOR, and many others. Thus, the involvement of this pathway is interesting as many of its targets also have redundant 
regulatory mechanisms that could serve to rescue the knockdown of signals in this pathway. Thus, we could expect enrichment of the 
MAPK signaling pathway as ErbB, and many of the TLRs interact with MAPK signaling as a downstream target.   
 
Figure 17. KEGG and Reactome analysis of the diminisher gene-set indicates the upregulation of TLR signaling. The most 
upregulated pathway exclusive to this gene-set is the ErbB signaling pathway, which is an upstream regulator of MAPK, JNK, calcium 
signaling, PI3K/Akt signaling to mTOR, and survival.   
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11. KEGG and Reactome pathway analysis of the enhancer gene-set indicates immune 
system involvement. 
 The enhancer gene-set was by far the smallest gene-set with only a quarter of the number 
of terms. Thus, the specificity of the enriched terms here is expected to be higher and is with 
Rap1 signaling having an almost 60-fold enrichment (Figure 18). Rap1 signaling is involved in 
cell-cell junctions, may serve as a regulator of MEK, a member of the MAPK family, and has 
been implicated in the oncogenesis of cancer. The diversity of downstream effectors, taken with 
the other enriched terms, provides support for its role in activating immune responses. 
Interestingly, even with the plethora of immune related terms in other gene-sets, JNK activity is 
exclusively found in this set. TP53 regulated transcription of DNA repair genes, and 
Transcriptional Regulation by TP53 indicates that disruptions to DNA repair or transcription 
resulted in an enhanced stress response. These results are in line with previous investigations and 
are in line with the expected phenotype of our model.  Impairment of transcription and DNA 
repair enzymes would likely result in a robust stress response that would seek to maintain 
homeostasis, and here results in a hormetic effect.   
 
 
 
 
 
Figure 18. KEGG and Reactome analysis of the enhancer gene-set indicate immune system involvement at multiple levels, with 
Rap1 signaling being the most enriched pathway. Rap1 signaling is involved in cell-cell junctions, may serve as a regulator of MEK, 
a member of the MAPK family, and has been implicated in the oncogenesis of cancer.  Its role is not fully defined, but it may serve to 
regulate diverse functions.  This information, taken with the other enriched terms, provides support for its role in activating immune 
responses as well as its relation to oncogenic p53 homolog TP53.   
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Discussion  
1. The rars-1 mutation affects a disproportionately large number of genes. 
 The initial number of hits in this protein kinase sub-library is surprisingly high as most 
genome-wide screens of the entire 12,000-20,000 gene library result in a similar number (100-
300) of hits. The significant enrichment for hits in this particular mutant is likely due to its role 
in cellular stress signaling combined with the enriched gene-set of the protein kinase sub-library. 
Additionally, this model is unique in that constitutive GFP reporter expression allowed us to 
detect increases as well as knockdowns. This variance permitted us to generate an additional 
enhancer gene-set.   
2. The enriched GO terms were involved in many cellular processes, most notably MAPK 
signaling and immune function. 
 DAVID analysis validated the contents of the kinase sub-library and demonstrated its 
involvement in essential cellular functions. In analyzing the regulators gene-set, we noted a 
prominent exclusion of GO term regulation of adult lifespan while terms related to immune 
regulation and stress response were maintained. The terms associated with the most significant 
reduction in GFP expression were associated with immune-related signaling, including calcium 
signaling, MAPK signaling, innate immune response, as well as many stress response terms, 
including osmotic stress response, which validates our model. An examination of regulators of 
osmotic stress response noted a significant overlap with genes upregulated in pathogen defense 
and found they activated similar transcription factors [96]. The diminishers of gpdh-1 revealed 
many similar patterns as the knockdown set, but with the addition of JNK kinases and Ras 
protein signal transduction. Combining the upregulated terms in these sets indicates a significant 
enrichment of terms associated with immune-related signaling through MAPK/JNK pathways 
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impacting the ISR. UPR, ER, oxidative, and heat stress activate immune signaling related 
kinases [97, 98]. The smaller enhancer gene-set involved many-fold fewer pathways. However, 
those were still involved in essential processes, including cell cycle decisions, chemosensory 
behavior, and notable only the purine metabolism pathway was enriched.   
3. Exploration of Reactome pathways illustrates a common thread linking enriched 
pathways to MAPK activity. 
 WEBGESTALT KEGG and Reactome analysis confirmed the findings of DAVID GO 
term enrichment analysis and illustrated the interconnections between the enriched terms. 
Reactome analysis of the pathways demonstrated interconnections between nearly all enriched 
terms across gene-sets intersecting with MAPK activation. Immune-related signals were 
transduced by multiple pathways that terminated on MAPK activation and, thus, subsequent 
upregulation of nuclear transcription of stress-responsive genes. Enriched pathways VEGF and 
VEGFR-VEGF2R signaling have functional connections to MAPK, Akt/mTORC, RAC1, RAS, 
L-Arg, PKC, and SPKK-1, which is related to FCER1. The enriched ERKs lead to RAS 
signaling as well. ErbB 2/4 signaling along with FCER1 and TAK1 is functionally connected to 
the RAF-MAPK cascade. Signaling through RAS is transmitted through the RAF-MAPK 
cascade as well to activate MAPK. There is also an RAF independent MAPK 1/3 activation, 
which includes the kinases mek-2 and mpk-1. The convergence of these pathways on MAPK 
signaling is quite interesting, though not wholly unexpected as MAPK signaling is involved in 
response to hypoxic, heat, osmotic, oxidative, proteotoxic, microgravity, and infection stress 
[rev. in 99]. MAPK is functionally connected to TP53, PI3K, MYD88, and may activate 
predicted TLR 3, which then activates TLR 2,4,5,9, and 10. Interestingly, C. elegans has only 
one TLR homolog, TIR, which is not involved in canonical TLR signaling to activate the p38 
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MAPK pathway [100]. These pathways have significant cross-talk and overlap with TP53, 
orthologous to human p53, regulating transcription of cell death, cell cycle, and DNA repair 
genes as well as regulating genes involved in the electron transport chain, carbohydrate 
metabolism, nucleotide metabolism, and reactive oxygen species detoxification. These pathways 
are modulated by the activity of mTORC and AMPK.  TP53 regulated apoptotic genes include 
innate immune response which includes MAPK activation. Innate immune signaling involves 
many diverse processes, and here we see genes involved in many different signaling pathways all 
converge on immune signaling, illustrating the importance of the ISR.  
4. Select kinases regulate responses to diverse stressors, and pathogens utilize many of the 
same immune signaling pathways in unique patterns to alter cellular transcription rapidly. 
An investigation of pesticide resistance found innate immune system components were 
essential and activated a rapid reprogramming of transcription [101]. Osmotic stress-regulated 
transcription shares common transcription factors with pathogen infection [96]. A quantitative 
genome-wide screen for antifungal innate immunity genes revealed regulation of diverse 
processes, including osmotic stress as well as a central role for the p38 MAPK pathway [102]. 
However, their library carried a defective pmk-1 clone limiting their conclusions. A screen for 
mutants regulating hypoxia resistance found many genes involving cell signaling, proteostasis, 
stress responses, metabolism, and transcription, indicating a different stressor activates a similar 
pattern of widespread transcriptional reprogramming [98]. Oxidative and heat stress were 
implicated as modulators of proteostasis along with insulin signaling during pathogen infection 
as part of the innate immune response [97, 103]. Oxidative stress-induced by lactate 
supplementation increased transcription of genes involved in the UPR, growth, and oxidative 
stress resistance [104]. Together, these papers illustrate striking levels of transcriptional 
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reprogramming and regulation by central stress-activated kinases which carry roles outside their 
function in innate immunity. Interestingly, exposure to various pathogens causes a unique 
upregulation of select immune functions to deliver a targeted response.  The response to various 
stressors also carries much overlap, but with unique aspects in each pathway.   
Figure 19. The C. elegans MAPK 
cascade is orthologous to the 
mammalian cascade and responds to 
similar stressors. 
a. In mammalian cells, binding of 
lipopolysaccharide to Toll-like 
receptors (TLRs) triggers the activation 
of a signaling cascade, which frees NF-
κB.  Free NF-κB drives the 
transcription of inflammatory response 
genes. Simultaneously, TAK1 activates 
the p38 mitogen-activated protein 
kinase (MAPK) cascade, which 
comprises the C. elegans NSY-1 
homolog ASK1, MKK3, MKK6, 
MKK4 and MKK7, and JUN N-
terminal kinase (JNK). p38 and JNK 
target the transcription factor activator 
protein 1 (AP1) to drive the 
transcription of host response genes.  
b | C. elegans has a homolog of TLR, 
TOL-1, but notably lacks MYD88, 
IKKβ, IKKγ, and NF-κB homologs. 
Instead, the NSY-1–SEK-1–PMK-1 
cassette is a central regulator of host 
defense in C. elegans and depends on the upstream protein TIR-1 for activity. In mammals, the TIR-1 homolog sterile α- and 
armadillo-motif-containing protein 1 (SARM1) negatively regulates TLR signaling, showing how the same protein can have 
opposite roles in different organisms. MAL, MYD88-adaptor-like protein (also known as TIRAP); NSY-1, neuronal symmetry 
family member 1; PMK-1, p38 MAPK family member 1; SEK-1, SAPK/ERK kinase 1; TAB, TAK1-binding protein 1; TRAM, 
TRIF-related adaptor molecule; TRIF, TIR-domain-containing adaptor protein inducing IFNβ.  
© Nature Reviews Immunology. Used with permission. 
5. MAPK signaling, specifically p38 MAPK, integrates stress regulatory pathways and has 
confirmed mammalian orthologs. 
 As nearly all enriched pathways led to MAPK signaling, we chose to investigate MAPK 
genes further to look for patterns or abnormalities. The MAPK pathway in C. elegans has 
orthologs in mammals and responds to similar environmental stressors (Figure 19). In the 
canonical p38 MAPK pathway in humans, lipopolysaccharide is bound by TLR4 which activates 
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downstream effectors MYD88/MAL and TRIF/TRAM which then activate IRAKs to TRAF6 to 
TAK1 which activates the mammalian ortholog of nsy-1, ASK1, which then activates MAPKKs 
to p38 and JNK which activates transcription factors FOS and JUN which mediate the 
transcription of stress responsive genes. In C. elegans, the only known ortholog of TLRs, TOL-1, 
does not function to activate the canonical MAPK cascade. Instead, another signal activates nsy-
1-sek-1-pmk-1-skn-1 to activate transcription of stress responsive genes [100]. In our data, RNAi 
of nsy-1 resulted in a profound lack of GFP expression, however, RNAi of the downstream 
kinases resulted in an enhancer, sek-1, or in the case of pmk-1 a highly variable GFP expression. 
This may suggest that nsy-1 has an additional regulatory function outside the MAPK cascade.   
6. The p38 MAPK pathway appears to have non-canonical functions. 
Indeed, a few other investigations have suggested additional roles of nsy-1. In an 
investigation of survival in response to pathogenic E. coli infection, it was suggested that nsy-1  
may regulate abf-3 and spp-1 to generate antimicrobial peptides [105]. An investigation of 
pesticide response found that the immune response was essential, particularly the MAPK cascade 
however, nsy-1 was uniquely not upregulated and the activation of these pathways varied across 
24 hours of exposure [101]. Mutants defective in nsy-1 were found to be susceptible to pathogens 
as well as osmotic stress, ER stress, oxidative stress [106] and DNA damage [107]. The 
canonical pathway was suggested to be unnecessary for osmotic stress responses which may 
again implicate a divergent function of nsy-1 [96], but other investigators claim the p38 MAPK 
pathway is essential [108]. Interestingly, nsy-1 plays a role in hypoxic stress and anoxia survival 
where it improves survival in the short term, but chronic activation may reduce survival.  In 
addition, this pathway is regulated in response to wounding [109]. Initial osmotic stress assays 
from our laboratory suggest that RNAi of nsy-1 in VP611 worms confers a survival advantage, 
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though further experiments are necessary to confirm these findings (data not shown). These 
findings suggest that nsy-1 serves additional roles outside of its canonical function and its role 
impacts resilience to many stressors. Interestingly, the same stressors relevant to rars-1 
deficiency are also impacted by nsy-1 which may suggest a common element or pathway.   
7. The role of nsy-1 in regulating stress responses and resilience to hypoxic, osmotic, and 
ROS stress indicates it plays an essential role in the mechanistic pathogenesis of important 
human diseases.  
Innate immune regulation occurs in response to diverse stressors including hypoxia, ROS, 
and osmotic stress. The elucidation of the functional roles of nsy-1 outside of the canonical p38 
MAPK pathway may illustrate connections which may shed light onto the unique innate immune 
activation patterns of various stressors and pathogens. Characterizing the role of nsy-1 with 
regard to hypoxic, ROS, and osmotic stress resistance in our rars-1 model may develop a greater 
understanding of signaling pathways necessary to understand human disease such as ischemic 
stroke. Regulation of hypoxia genes could shed light onto the mechanisms of exercise induced 
stress adaptation which may be investigated with the use of blood flow restriction training. 
Understanding the role nsy-1 plays in anoxic survival in short- and long-term exposures may 
illustrate the signaling pathways activated by occlusive exercise modalities.   
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Conclusion 
 Rrt-1 knockdown mediated gpdh-1 synthesis is regulated by many kinases affecting 
diverse cellular processes, but primarily involving immune system function.   
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Appendix 
W03F11.2 T06C10.3 E01H11.1 C08H9.5 F16B12.5 
B0207.7 T06C10.6 F59F3.5 R03D7.5 F18H3.5 
C10H11.9 F42G8.3 F54F7.5 R166.5 R01E6.1 
M04F3.3 F42G8.4 F46F6.2 Y38F1A.10 T04C10.1 
F21F3.2 C09G4.2 ZC504.3 Y39G8B.5 F09A5.2 
T09B4.7 C49C8.1 M79.1 Y39G8C.2 C30G4.3 
ZC581.7 T04B2.2 F22H10.1 C29F9.7 B0205.7 
ZC581.9 Y43C5B.2 F46F2.2 T17A3.8 F28H6.1 
F22D6.5 W01B6.5 K09A9.1 W04B5.5 B0207.4 
E02D9.1 ZK593.9 B0218.3 W02B3.2 B0478.1 
C01H6.9 Y69E1A.3 Y39G10AL.3 C24A1.3 Y69F12A.1 
T21G5.1 K07F5.4 M176.7 F45H7.4 Y47D3A.16 
H05L14.1 F32B6.10 Y60A3A.12 C28A5.6 Y71F9AL.2 
F22D6.1 M7.7 Y60A3A.1 F25F2.1 F58D5.4 
F39H11.3 T13H10.1 Y50D7A.3 C03C10.1 C30F8.4 
F52B5.2 T25B9.4 M03C11.1 C03C10.2 W09C5.5 
C36B1.10 C05C12.1 F33D11.7 T15B12.2 Y53F4B.1 
Y106G6D.4 H01G02.2 R06A10.4 F35G12.3 ZK596.2 
Y106G6E.6 F22B3.8 Y71F9B.7 W03A5.1 ZC373.3 
F33E2.2 ZK617.1 W10G6.2 F43C1.2 F39F10.3 
Y18H1A.10 F49E11.1 F23C8.7 R151.4 F32D8.1 
Y39G10AR.3 Y105C5A.24 F23C8.8 F31E3.2 C09D1.1 
ZK909.2 K09B11.1 C34G6.5 C05D10.2 K03E5.3 
F46F5.2 K09B11.5 C09D4.3 C49H3.1 F59A3.8 
F22E5.3 Y38H8A.4 ZC581.2 C07G1.3 B0414.7 
ZC239.7 Y43D4A.6 H37N21.1 W01B6.2 C34B2.3 
C16A11.3 C06A12.4 F52F12.3 C04G2.2 H25P06.2 
C17F4.6 Y116A8C.24 Y106G6A.1 W08D2.8 T17A3.1 
F53C3.1 F11E6.8 C35E7.10 C08F8.6 B0285.1 
M03A1.1 Y116A8C.38 T27C10.6 C27D8.1 F57B9.8 
F28B12.3 T25E12.4 Y106G6E.1 C49C3.2 C04H5.3 
C33F10.2 DC2.7 T20F10.1 W06H8.8 ZK896.8 
C34F11.5 K08B12.5 Y18D10A.5 T10H9.2 C49C3.10 
F59A6.1 K11C4.1 F49B2.5 K07C11.2 Y59A8B.23 
F41G3.5 C16D9.2 Y47G6A.5 F55C5.7 ZC404.9 
C41C4.4 F38E1.3 Y47G6A.13 F46G11.3 ZC449.3 
R09D1.12 R90.1 T05A7.6 F11D5.3 F13B9.5 
F35H8.7 T08G5.2 F59E12.2 F35C8.1 C44H4.6 
K08F8.1 H39E23.1 F59A6.4 F08F1.1 E02H4.6 
Y53C12A.1 C53A5.4 C32D5.2 F19C6.1 F15A2.6 
ZK970.6 T01G5.1 B0495.2 F42G10.2 C04A11.3 
C08H9.8 R10D12.10 C56C10.6 VZC374L.1 Y50D4B.6 
W02B12.12 R04A9.7 M176.6 F17E5.1 Y51B9A.9 
C45G9.1 F28C10.3 R134.1 T24D5.4 F55A8.2 
D1044.8 H42K12.1 R134.2 F58A3.2 B0218.5 
F26A1.3 K02E10.7 C41C4.4 ZC504.4 C38C3.4 
C05D2.1 T01H10.4 ZK1067.1 C44C10.7 Y42A5A.4 
C05H8.1 F59F3.1 C01G6.8 F59F5.3 ZC412.2 
R13F6.6 D1073.1 ZK970.5 F19H6.1 T01G5.1 
C06E8.3 F22F1.2 ZK938.5 E02H4.3 F40A3.5 
Table 23. Complete screen results for regulators of gpdh-1 identified as knockdown (red), 
diminisher (yellow), and enhancers (green). 
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F53G12.6 Y111B2A.1 F52E1.4 
ZC123.4 T27E9.3 T19A5.2 
K12C11.4 Y55D5A.5 C50F4.10 
T01A4.1 B0545.1 C45B11.1 
W09C3.1 K11H12.9 C12D8.10 
W03G9.5 F29C4.1 F23H12.6 
ZC581.1 C44C8.6 F57F5.5 
R06C7.8 K07A9.2 W07G4.3 
C54G4.1 F18F11.5 F58H12.1 
M04C9.5 T07A9.3 C16B8.1 
F26E4.5 ZC416.4 F20B6.8 
T01H8.1 W03G1.6 T07F12.4 
W04G5.6 C18H7.4 C01C4.3 
B0511.4 T26C12.4 C24A8.4 
Y54E10BL.6 R11E3.1 C03B1.5 
Y65B4A.9 F36H12.8 C36B7.1 
ZK622.1 F36H12.9 F47F2.1 
F08B1.2 ZK354.2 T14E8.1 
F09E5.1 Y52D5A.2 F35C8.2 
C25H3.1 Y4C6A.1 C09B8.7 
C29H12.5 C09B9.4 C25F6.4 
EEED8.9 T11F8.4 K08A8.1 
B0252.1 T22B11.3 F46C3.1 
F54H5.2 C39H7.1 R03G5.2 
T19D12.5 C55C3.4 K08H2.5 
T05C12.1 W03F8.2 K04C1.5 
M05D6.1 F55G1.8 T01C8.1 
C14A4.13 Y73B6A.2 B0464.5 
R05H5.4 D2024.1 F35C8.3 
ZK930.1 C25A8.5 F35C11.3 
Y81G3A.3 B0496.3 ZK354.6 
F49C5.4 C46C2.1 B0240.3 
Y38E10A.8 K11E8.1 
 
T17E9.1 F01D4.3 
 
C14B9.4 C04G6.1 
 
K06H7.8 T25B9.5 
 
R107.4 C10C6.1 
 
B0523.1 Y38H8A.3 
 
ZK507.1 M01B2.1 
 
ZK507.3 F21H7.9 
 
PAR2.3 T03D8.5 
 
Y52D3.1 T08D2.7 
 
M03C11.1 Y39H10A.7 
 
D2045.5 Y38H6C.20 
 
D2045.7 R02C2.1 
 
C07A9.3 R02C2.2 
 
T05G5.3 C38C3.4 
 
Y79H2A.11 C24G6.2 
 
W06F12.1 K11D12.10 
 
W06F12.3 F09G2.1 
 
Table 24. The complete list of screened genes identified as not a significant regulator of 
gpdh-1 (null set). 
 
 
GO Term Biological Process % PValue Fold Enrichment Bonferroni Benjamini FDR 
GO:0006468 protein phosphorylation 98.6 0.00E+00 27 0.00E+00 0.00E+00 0.00E+00 
GO:0016310 phosphorylation 56.4 3.07E-240 19 1.62E-237 8.11E-238 4.46E-237 
GO:0018105 peptidyl-serine phosphorylation 29.6 2.30E-143 26 1.22E-140 4.06E-141 3.34E-140 
GO:0008360 regulation of cell shape 20.8 3.37E-95 25 1.78E-92 4.45E-93 4.89E-92 
GO:0035556 intracellular signal transduction 17.5 5.73E-55 13 3.02E-52 5.04E-53 8.31E-52 
GO:0030154 cell differentiation 13.2 6.28E-31 9 3.31E-28 3.31E-29 9.11E-28 
GO:0045087 innate immune response 13.2 1.67E-19 5 8.79E-17 5.50E-18 2.42E-16 
GO:0007169 transmembrane receptor protein tyrosine kinase  12.6 7.97E-61 28 4.21E-58 8.42E-59 1.16E-57 
GO:0007275 multicellular organism development 11.8 7.28E-12 3 3.84E-09 2.13E-10 1.06E-08 
GO:0008340 determination of adult lifespan 11.5 3.08E-02 1 1.00E+00 2.21E-01 3.65E+01 
GO:0018108 peptidyl-tyrosine phosphorylation 11.0 1.69E-53 28 8.93E-51 1.28E-51 2.45E-50 
GO:0038083 peptidyl-tyrosine autophosphorylation 10.4 1.60E-50 28 8.46E-48 1.06E-48 2.33E-47 
GO:0042127 regulation of cell proliferation 10.1 5.58E-23 8 2.95E-20 2.11E-21 8.10E-20 
GO:0007165 signal transduction 7.7 3.06E-04 2 1.49E-01 4.35E-03 4.43E-01 
GO:0023014 signal transduction by protein phosphorylation 6.6 1.84E-31 28 9.72E-29 1.08E-29 2.67E-28 
GO:0006182 cGMP biosynthetic process 6.3 4.03E-25 21 2.13E-22 1.77E-23 5.84E-22 
GO:0009190 cyclic nucleotide biosynthetic process 6.3 5.55E-24 19 2.93E-21 2.25E-22 8.05E-21 
GO:0000165 MAPK cascade 5.5 1.22E-25 28 6.46E-23 5.87E-24 1.77E-22 
GO:0007049 cell cycle 4.9 1.64E-06 4 8.67E-04 3.62E-05 2.38E-03 
GO:0046777 protein autophosphorylation 4.4 2.51E-21 30 1.33E-18 8.85E-20 3.65E-18 
GO:0016055 Wnt signaling pathway 4.1 2.20E-10 10 1.16E-07 6.12E-09 3.20E-07 
GO:0007399 nervous system development 4.1 1.51E-07 6 7.99E-05 3.63E-06 2.20E-04 
GO:0006935 chemotaxis 3.8 2.38E-08 8 1.26E-05 5.99E-07 3.46E-05 
GO:0051301 cell division 3.8 3.50E-04 3 1.69E-01 4.86E-03 5.07E-01 
GO:0006952 defense response 3.6 3.92E-04 3 1.87E-01 5.04E-03 5.68E-01 
GO:0018107 peptidyl-threonine phosphorylation 3.3 7.97E-15 27 4.22E-12 2.48E-13 1.16E-11 
GO:0007635 chemosensory behavior 3.0 4.69E-07 8 2.48E-04 1.08E-05 6.81E-04 
GO:0051321 meiotic cell cycle 3.0 1.69E-05 6 8.91E-03 3.44E-04 2.46E-02 
GO:0040024 dauer larval development 2.7 2.20E-04 5 1.10E-01 3.52E-03 3.19E-01 
GO:0007067 mitotic nuclear division 2.7 1.09E-02 3 9.97E-01 9.85E-02 1.48E+01 
GO:0016477 cell migration 2.5 4.03E-02 2 1.00E+00 2.67E-01 4.50E+01 
GO:0000278 mitotic cell cycle 2.2 8.09E-09 23 4.27E-06 2.14E-07 1.17E-05 
GO:0010628 positive regulation of gene expression 2.2 4.45E-04 6 2.09E-01 5.58E-03 6.44E-01 
GO:0006897 endocytosis 2.2 5.84E-04 5 2.66E-01 7.15E-03 8.45E-01 
GO:0007126 meiotic nuclear division 2.2 6.11E-02 2 1.00E+00 3.58E-01 5.99E+01 
GO:0051726 regulation of cell cycle 1.9 9.51E-05 9 4.90E-02 1.79E-03 1.38E-01 
GO:0050832 defense response to fungus 1.9 1.20E-04 9 6.16E-02 2.05E-03 1.75E-01 
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GO:0009408 response to heat 1.9 3.29E-02 3 1.00E+00 2.32E-01 3.85E+01 
GO:0007411 axon guidance 1.9 7.96E-02 2 1.00E+00 4.26E-01 7.00E+01 
GO:1902074 response to salt 1.6 1.91E-05 16 1.00E-02 3.73E-04 2.77E-02 
GO:0045167 asymmetric protein localization involved in cell fate  1.6 3.04E-04 10 1.48E-01 4.44E-03 4.40E-01 
GO:0007163 establishment or maintenance of cell polarity 1.6 3.88E-04 9 1.85E-01 5.12E-03 5.62E-01 
GO:0006972 hyperosmotic response 1.6 6.10E-04 8 2.76E-01 7.30E-03 8.82E-01 
GO:0045138 nematode male tail tip morphogenesis 1.6 9.25E-02 2 1.00E+00 4.61E-01 7.55E+01 
GO:1903616 MAPK cascade involved in axon regeneration 1.4 1.33E-05 27 7.02E-03 2.82E-04 1.94E-02 
GO:0002376 immune system process 1.4 1.04E-04 18 5.34E-02 1.89E-03 1.51E-01 
GO:0010035 response to inorganic substance 1.4 1.69E-04 16 8.54E-02 2.79E-03 2.45E-01 
GO:0061067 negative regulation of dauer larval development 1.4 2.59E-04 15 1.28E-01 4.02E-03 3.75E-01 
GO:0031103 axon regeneration 1.4 3.79E-04 13 1.81E-01 5.12E-03 5.49E-01 
GO:0033554 cellular response to stress 1.4 1.26E-03 10 4.87E-01 1.44E-02 1.82E+00 
GO:0001556 oocyte maturation 1.4 2.02E-03 9 6.56E-01 2.25E-02 2.89E+00 
GO:0042594 response to starvation 1.4 2.28E-02 5 1.00E+00 1.78E-01 2.85E+01 
GO:0010172 embryonic body morphogenesis 1.4 2.51E-02 4 1.00E+00 1.89E-01 3.08E+01 
GO:0050830 defense response to Gram-positive bacterium 1.4 3.53E-02 4 1.00E+00 2.44E-01 4.06E+01 
GO:0051729 germline cell cycle switching, mitotic to meiotic cell cycle 1.4 5.11E-02 4 1.00E+00 3.19E-01 5.33E+01 
GO:0007283 spermatogenesis 1.4 8.30E-02 3 1.00E+00 4.35E-01 7.15E+01 
GO:0000186 activation of MAPKK activity 1.1 1.18E-04 32 6.04E-02 2.07E-03 1.71E-01 
GO:0007168 receptor guanylyl cyclase signaling pathway 1.1 1.18E-04 32 6.04E-02 2.07E-03 1.71E-01 
GO:0000187 activation of MAPK activity 1.1 2.88E-04 26 1.41E-01 4.34E-03 4.17E-01 
GO:0006986 response to unfolded protein 1.1 9.62E-04 18 3.98E-01 1.12E-02 1.39E+00 
GO:1903998 regulation of eating behavior 1.1 2.20E-03 14 6.88E-01 2.40E-02 3.15E+00 
GO:0093002 response to nematicide 1.1 4.13E-03 12 8.88E-01 4.28E-02 5.83E+00 
GO:0008286 insulin receptor signaling pathway 1.1 4.13E-03 12 8.88E-01 4.28E-02 5.83E+00 
GO:0030536 larval feeding behavior 1.1 5.38E-03 11 9.42E-01 5.43E-02 7.53E+00 
GO:0040040 thermosensory behavior 1.1 6.84E-03 10 9.73E-01 6.61E-02 9.48E+00 
GO:0007409 axonogenesis 1.1 8.50E-03 9 9.89E-01 8.01E-02 1.17E+01 
GO:0061065 regulation of dauer larval development 1.1 1.25E-02 8 9.99E-01 1.10E-01 1.67E+01 
GO:0032436 positive regulation of proteasomal ubiquitin-dependent  1.1 1.48E-02 8 1.00E+00 1.25E-01 1.95E+01 
GO:0050920 regulation of chemotaxis 1.1 1.74E-02 7 1.00E+00 1.43E-01 2.25E+01 
GO:0008356 asymmetric cell division 1.1 7.13E-02 4 1.00E+00 3.98E-01 6.58E+01 
GO:0048691 positive regulation of axon extension involved  0.8 2.86E-03 32 7.79E-01 3.03E-02 4.07E+00 
GO:0038066 p38MAPK cascade 0.8 2.86E-03 32 7.79E-01 3.03E-02 4.07E+00 
GO:0035404 histone-serine phosphorylation 0.8 2.86E-03 32 7.79E-01 3.03E-02 4.07E+00 
GO:0007257 activation of JUN kinase activity 0.8 5.59E-03 24 9.48E-01 5.54E-02 7.82E+00 
GO:0016048 detection of temperature stimulus 0.8 9.13E-03 19 9.92E-01 8.43E-02 1.25E+01 
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GO:0061404 positive regulation of transcription from RNA polymerase 0.8 9.13E-03 19 9.92E-01 8.43E-02 1.25E+01 
GO:1901215 negative regulation of neuron death 0.8 9.13E-03 19 9.92E-01 8.43E-02 1.25E+01 
GO:1902097 positive regulation of transcription from RNA polymerase 0.8 9.13E-03 19 9.92E-01 8.43E-02 1.25E+01 
GO:0050893 sensory processing 0.8 1.34E-02 16 9.99E-01 1.16E-01 1.78E+01 
GO:0046688 response to copper ion 0.8 1.34E-02 16 9.99E-01 1.16E-01 1.78E+01 
GO:0044333 Wnt signaling pathway involved in digestive tract  0.8 1.84E-02 14 1.00E+00 1.48E-01 2.36E+01 
GO:0050807 regulation of synapse organization 0.8 2.40E-02 12 1.00E+00 1.84E-01 2.97E+01 
GO:0007265 Ras protein signal transduction 0.8 3.03E-02 11 1.00E+00 2.21E-01 3.60E+01 
GO:0051782 negative regulation of cell division 0.8 3.71E-02 10 1.00E+00 2.51E-01 4.22E+01 
GO:0006970 response to osmotic stress 0.8 3.71E-02 10 1.00E+00 2.51E-01 4.22E+01 
GO:0050913 sensory perception of bitter taste 0.8 3.71E-02 10 1.00E+00 2.51E-01 4.22E+01 
GO:0055059 asymmetric neuroblast division 0.8 4.44E-02 9 1.00E+00 2.87E-01 4.82E+01 
GO:0030516 regulation of axon extension 0.8 4.44E-02 9 1.00E+00 2.87E-01 4.82E+01 
GO:0043052 thermotaxis 0.8 4.44E-02 9 1.00E+00 2.87E-01 4.82E+01 
GO:0007608 sensory perception of smell 0.8 5.22E-02 8 1.00E+00 3.21E-01 5.40E+01 
GO:0051932 synaptic transmission, GABAergic 0.8 6.04E-02 7 1.00E+00 3.59E-01 5.95E+01 
GO:0007178 transmembrane receptor protein serine/threonine kinase  0.8 6.04E-02 7 1.00E+00 3.59E-01 5.95E+01 
GO:0050896 response to stimulus 0.8 7.81E-02 6 1.00E+00 4.23E-01 6.93E+01 
GO:0048489 synaptic vesicle transport 0.8 8.75E-02 6 1.00E+00 4.49E-01 7.35E+01 
GO:0034976 response to endoplasmic reticulum stress 0.8 8.75E-02 6 1.00E+00 4.49E-01 7.35E+01 
GO:1904746 negative regulation of apoptotic process involved in  0.5 6.15E-02 32 1.00E+00 3.56E-01 6.02E+01 
GO:0089700 protein kinase D signaling 0.5 6.15E-02 32 1.00E+00 3.56E-01 6.02E+01 
GO:0035419 activation of MAPK activity involved in innate immune  0.5 6.15E-02 32 1.00E+00 3.56E-01 6.02E+01 
GO:0060631 regulation of meiosis I 0.5 6.15E-02 32 1.00E+00 3.56E-01 6.02E+01 
GO:0043988 histone H3-S28 phosphorylation 0.5 6.15E-02 32 1.00E+00 3.56E-01 6.02E+01 
GO:0007258 JUN phosphorylation 0.5 6.15E-02 32 1.00E+00 3.56E-01 6.02E+01 
GO:0043987 histone H3-S10 phosphorylation 0.5 6.15E-02 32 1.00E+00 3.56E-01 6.02E+01 
GO:0050891 multicellular organismal water homeostasis 0.5 9.08E-02 21 1.00E+00 4.58E-01 7.49E+01 
GO:1904781 positive regulation of protein localization to centrosome 0.5 9.08E-02 21 1.00E+00 4.58E-01 7.49E+01 
GO:0000082 G1/S transition of mitotic cell cycle 0.5 9.08E-02 21 1.00E+00 4.58E-01 7.49E+01 
GO:0007254 JNK cascade 0.5 9.08E-02 21 1.00E+00 4.58E-01 7.49E+01 
GO:0009611 response to wounding 0.5 9.08E-02 21 1.00E+00 4.58E-01 7.49E+01 
GO:0042992 negative regulation of transcription factor import into 0.5 9.08E-02 21 1.00E+00 4.58E-01 7.49E+01 
GO:2000369 regulation of clathrin-mediated endocytosis 0.5 9.08E-02 21 1.00E+00 4.58E-01 7.49E+01 
GO:0030308 negative regulation of cell growth 0.5 9.08E-02 21 1.00E+00 4.58E-01 7.49E+01 
GO:0032793 positive regulation of CREB transcription factor activity 0.5 9.08E-02 21 1.00E+00 4.58E-01 7.49E+01 
Table 25. Biological process GO term analysis of the protein kinase sub-library. 
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GO Term Cellular Component % PValue Fold Enrichment Bonferroni Benjamini FDR 
GO:0005737 cytoplasm 48.5 8.87E-75 4 9.41E-73 9.41E-73 9.96E-72 
GO:0005634 nucleus 36.7 2.16E-28 3 2.29E-26 7.64E-27 2.43E-25 
GO:0005886 plasma membrane 14.8 1.27E-14 3 1.35E-12 2.26E-13 1.43E-11 
GO:0031234 extrinsic component of cytoplasmic side of plasma membrane 10.4 6.10E-52 31 6.46E-50 3.23E-50 6.84E-49 
GO:0030424 axon 6.8 5.83E-13 6 6.18E-11 8.83E-12 6.54E-10 
GO:0042995 cell projection 6.6 3.11E-15 9 3.30E-13 6.59E-14 3.49E-12 
GO:0008074 guanylate cyclase complex, soluble 6.0 2.13E-25 24 2.25E-23 5.63E-24 2.39E-22 
GO:0005622 intracellular 5.5 1.15E-02 2 7.08E-01 6.60E-02 1.22E+01 
GO:0043025 neuronal cell body 4.4 5.56E-06 4 5.89E-04 5.36E-05 6.24E-03 
GO:0043204 perikaryon 3.8 1.14E-11 13 1.20E-09 1.51E-10 1.28E-08 
GO:0030425 dendrite 3.8 1.47E-07 7 1.56E-05 1.74E-06 1.65E-04 
GO:0005856 cytoskeleton 3.0 9.35E-02 2 1.00E+00 3.41E-01 6.68E+01 
GO:0005929 cilium 2.7 5.13E-06 8 5.43E-04 5.44E-05 5.75E-03 
GO:0005938 cell cortex 2.5 1.79E-03 4 1.73E-01 1.26E-02 2.00E+00 
GO:0005813 centrosome 2.2 7.17E-04 5 7.32E-02 5.41E-03 8.01E-01 
GO:0005694 chromosome 1.9 4.06E-02 3 9.88E-01 2.07E-01 3.72E+01 
GO:0005815 microtubule organizing center 1.6 4.16E-04 9 4.32E-02 3.67E-03 4.66E-01 
GO:0031513 nonmotile primary cilium 1.6 4.51E-02 3 9.92E-01 2.17E-01 4.04E+01 
GO:0043005 neuron projection 1.6 5.23E-02 3 9.97E-01 2.37E-01 4.53E+01 
GO:0031430 M band 1.4 6.76E-03 6 5.13E-01 4.14E-02 7.33E+00 
GO:0016324 apical plasma membrane 1.4 9.42E-02 3 1.00E+00 3.32E-01 6.70E+01 
GO:0031672 A band 1.1 6.59E-04 21 6.75E-02 5.36E-03 7.37E-01 
GO:0000793 condensed chromosome 1.1 6.55E-02 4 9.99E-01 2.59E-01 5.32E+01 
GO:0044306 neuron projection terminus 0.8 4.34E-03 27 3.69E-01 2.84E-02 4.76E+00 
GO:0051233 spindle midzone 0.8 5.49E-02 8 9.97E-01 2.29E-01 4.70E+01 
GO:0032133 chromosome passenger complex 0.5 5.41E-02 36 9.97E-01 2.35E-01 4.64E+01 
GO:0000780 condensed nuclear chromosome, centromeric region 0.5 5.41E-02 36 9.97E-01 2.35E-01 4.64E+01 
Table 26. Cellular component GO term analysis of the protein kinase sub-library.
 
 
GO Term Biological Process % PValue Fold Enrichment Bonferroni Benjamini FDR 
GO:0016310 phosphorylation 55.8 5.49E-147 18.7 2.10E-144 1.05E-144 7.62E-144 
GO:0018105 peptidyl-serine phosphorylation 30.4 8.05E-90 27.1 3.08E-87 1.03E-87 1.12E-86 
GO:0008360 regulation of cell shape 20.8 1.08E-57 24.8 4.15E-55 1.04E-55 1.50E-54 
GO:0035556 intracellular signal transduction 17.5 9.29E-35 13.3 3.56E-32 5.08E-33 1.29E-31 
GO:0030154 cell differentiation 13.3 1.82E-20 8.7 6.96E-18 7.74E-19 2.52E-17 
GO:0045087 innate immune response 13.3 3.52E-13 4.9 1.35E-10 9.64E-12 4.88E-10 
GO:0007169 transmembrane receptor protein tyrosine kinase  12.9 1.36E-37 28.5 5.22E-35 1.04E-35 1.89E-34 
GO:0018108 peptidyl-tyrosine phosphorylation 11.7 6.89E-35 30.3 2.64E-32 4.40E-33 9.55E-32 
GO:0038083 peptidyl-tyrosine autophosphorylation 10.8 7.26E-32 29.4 2.78E-29 3.48E-30 1.01E-28 
GO:0042127 regulation of cell proliferation 10.4 1.39E-15 8.4 5.53E-13 5.53E-14 2.00E-12 
GO:0007275 multicellular organism development 10.0 1.06E-05 2.9 4.05E-03 2.14E-04 1.47E-02 
GO:0007165 signal transduction 8.3 1.02E-03 2.3 3.25E-01 1.69E-02 1.41E+00 
GO:0006182 cGMP biosynthetic process 6.3 2.50E-15 20.8 9.35E-13 8.50E-14 3.39E-12 
GO:0009190 cyclic nucleotide biosynthetic process 6.3 9.71E-15 19.2 3.70E-12 3.08E-13 1.34E-11 
GO:0023014 signal transduction by protein phosphorylation 5.0 2.05E-12 21.6 7.86E-10 5.24E-11 2.84E-09 
GO:0007049 cell cycle 5.0 1.40E-04 4.2 5.21E-02 2.54E-03 1.93E-01 
GO:0046777 protein autophosphorylation 4.6 1.84E-13 31.5 7.03E-11 5.41E-12 2.54E-10 
GO:0016055 Wnt signaling pathway 4.6 5.36E-08 10.7 2.05E-05 1.14E-06 7.43E-05 
GO:0051301 cell division 4.2 2.01E-03 3.6 5.37E-01 2.81E-02 2.74E+00 
GO:0018107 peptidyl-threonine phosphorylation 3.8 7.41E-11 31.3 2.84E-08 1.77E-09 1.03E-07 
GO:0000165 MAPK cascade 3.8 1.03E-08 19.0 3.95E-06 2.32E-07 1.43E-05 
GO:0006935 chemotaxis 3.3 1.90E-04 6.6 7.02E-02 3.30E-03 2.63E-01 
GO:0051321 meiotic cell cycle 2.9 1.50E-03 5.6 4.37E-01 2.36E-02 2.06E+00 
GO:0007399 nervous system development 2.9 5.88E-03 4.3 8.95E-01 7.25E-02 7.85E+00 
GO:0006952 defense response 2.9 3.80E-02 2.8 1.00E+00 3.03E-01 4.15E+01 
GO:0016477 cell migration 2.9 4.20E-02 2.7 1.00E+00 3.17E-01 4.48E+01 
GO:0051726 regulation of cell cycle 2.5 1.31E-04 11.7 4.89E-02 2.50E-03 1.81E-01 
GO:0007635 chemosensory behavior 2.5 1.58E-03 6.9 4.54E-01 2.39E-02 2.17E+00 
GO:0006897 endocytosis 2.5 2.62E-03 6.2 6.34E-01 3.41E-02 3.57E+00 
GO:0045138 nematode male tail tip morphogenesis 2.5 2.07E-02 3.8 1.00E+00 1.90E-01 2.51E+01 
GO:0050832 defense response to fungus 2.1 1.80E-03 9.4 4.98E-01 2.61E-02 2.46E+00 
GO:0040024 dauer larval development 2.1 4.82E-02 3.6 1.00E+00 3.37E-01 4.96E+01 
GO:0045167 asymmetric protein localization involved in cell fate  1.7 7.46E-03 9.7 9.43E-01 8.58E-02 9.86E+00 
GO:0007163 establishment or maintenance of cell polarity 1.7 8.58E-03 9.3 9.63E-01 9.51E-02 1.13E+01 
GO:0006972 hyperosmotic response 1.7 1.11E-02 8.5 9.86E-01 1.15E-01 1.43E+01 
GO:0010172 embryonic body morphogenesis 1.7 3.68E-02 5.4 1.00E+00 3.02E-01 4.06E+01 
GO:0050830 defense response to Gram-positive bacterium 1.7 4.80E-02 4.9 1.00E+00 3.42E-01 4.95E+01 
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GO:0000186 activation of MAPKK activity 1.3 2.44E-03 36.5 6.07E-01 3.28E-02 3.32E+00 
GO:1903616 MAPK cascade involved in axon regeneration 1.3 5.93E-03 24.3 8.97E-01 7.08E-02 7.91E+00 
GO:0050807 regulation of synapse organization 1.3 1.08E-02 18.2 9.84E-01 1.15E-01 1.39E+01 
GO:0006970 response to osmotic stress 1.3 1.68E-02 14.6 9.99E-01 1.65E-01 2.10E+01 
GO:0050913 sensory perception of bitter taste 1.3 1.68E-02 14.6 9.99E-01 1.65E-01 2.10E+01 
GO:0051782 negative regulation of cell division 1.3 1.68E-02 14.6 9.99E-01 1.65E-01 2.10E+01 
GO:0010035 response to inorganic substance 1.3 1.68E-02 14.6 9.99E-01 1.65E-01 2.10E+01 
GO:0061067 negative regulation of dauer larval development 1.3 2.03E-02 13.3 1.00E+00 1.91E-01 2.48E+01 
GO:0031103 axon regeneration 1.3 2.41E-02 12.2 1.00E+00 2.13E-01 2.86E+01 
GO:1902074 response to salt 1.3 2.41E-02 12.2 1.00E+00 2.13E-01 2.86E+01 
GO:0032436 positive regulation of proteasomal ubiquitin 1.3 4.64E-02 8.6 1.00E+00 3.39E-01 4.82E+01 
GO:0001556 oocyte maturation 1.3 5.15E-02 8.1 1.00E+00 3.50E-01 5.19E+01 
GO:0089700 protein kinase D signaling 0.8 4.05E-02 48.6 1.00E+00 3.14E-01 4.36E+01 
GO:0035404 histone-serine phosphorylation 0.8 6.02E-02 32.4 1.00E+00 3.91E-01 5.77E+01 
GO:1904781 positive regulation of protein localization 0.8 6.02E-02 32.4 1.00E+00 3.91E-01 5.77E+01 
GO:0007254 JNK cascade 0.8 6.02E-02 32.4 1.00E+00 3.91E-01 5.77E+01 
GO:0000082 G1/S transition of mitotic cell cycle 0.8 6.02E-02 32.4 1.00E+00 3.91E-01 5.77E+01 
GO:2000369 regulation of clathrin-mediated endocytosis 0.8 6.02E-02 32.4 1.00E+00 3.91E-01 5.77E+01 
GO:0038066 p38MAPK cascade 0.8 6.02E-02 32.4 1.00E+00 3.91E-01 5.77E+01 
GO:0022604 regulation of cell morphogenesis 0.8 7.94E-02 24.3 1.00E+00 4.76E-01 6.82E+01 
GO:0007168 receptor guanylyl cyclase signaling pathway 0.8 7.94E-02 24.3 1.00E+00 4.76E-01 6.82E+01 
GO:0045732 positive regulation of protein catabolic process 0.8 9.83E-02 19.5 1.00E+00 5.47E-01 7.62E+01 
GO:1901215 negative regulation of neuron death 0.8 9.83E-02 19.5 1.00E+00 5.47E-01 7.62E+01 
GO:0016048 detection of temperature stimulus 0.8 9.83E-02 19.5 1.00E+00 5.47E-01 7.62E+01 
GO:1902097 positive regulation of transcription from RNA 0.8 9.83E-02 19.5 1.00E+00 5.47E-01 7.62E+01 
GO:0030509 BMP signaling pathway 0.8 9.83E-02 19.5 1.00E+00 5.47E-01 7.62E+01 
Table 27. Biological process GO term analysis for the regulators gene-set.  
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GO Term Cellular Component % PValue Fold Enrichment Bonferroni Benjamini FDR 
GO:0005737 cytoplasm 45.4 4.58E-43 4.0 4.03E-41 4.03E-41 4.96E-40 
GO:0005634 nucleus 36.3 6.78E-19 2.6 5.97E-17 1.99E-17 7.34E-16 
GO:0005886 plasma membrane 15.4 5.55E-11 3.5 4.88E-09 9.77E-10 6.01E-08 
GO:0031234 extrinsic component of cytoplasmic side of plasma membrane 10.8 3.45E-33 33.3 3.04E-31 1.52E-31 3.74E-30 
GO:0008074 guanylate cyclase complex, soluble 5.8 4.67E-15 23.9 4.10E-13 1.03E-13 5.05E-12 
GO:0042995 cell projection 5.8 2.62E-08 7.7 2.31E-06 3.84E-07 2.84E-05 
GO:0030424 axon 5.8 1.21E-06 5.6 1.07E-04 1.52E-05 1.31E-03 
GO:0043025 neuronal cell body 3.8 3.10E-03 3.7 2.39E-01 2.25E-02 3.30E+00 
GO:0030425 dendrite 3.3 4.10E-04 5.8 3.54E-02 3.27E-03 4.43E-01 
GO:0043204 perikaryon 2.9 4.87E-05 10.4 4.28E-03 5.36E-04 5.28E-02 
GO:0005929 cilium 2.9 1.87E-04 8.2 1.63E-02 1.64E-03 2.02E-01 
GO:0005813 centrosome 2.1 1.60E-02 5.1 7.58E-01 9.65E-02 1.60E+01 
GO:0005694 chromosome 2.1 7.99E-02 3.1 9.99E-01 3.50E-01 5.94E+01 
GO:0031672 A band 1.7 1.81E-04 32.2 1.58E-02 1.76E-03 1.95E-01 
GO:0031430 M band 1.7 1.29E-02 8.0 6.80E-01 8.40E-02 1.31E+01 
GO:0032133 chromosome passenger complex 0.8 3.50E-02 56.3 9.57E-01 1.89E-01 3.20E+01 
GO:0000780 condensed nuclear chromosome, centromeric region 0.8 3.50E-02 56.3 9.57E-01 1.89E-01 3.20E+01 
GO:0031616 spindle pole centrosome 0.8 6.89E-02 28.2 9.98E-01 3.25E-01 5.38E+01 
GO:0031528 microvillus membrane 0.8 6.89E-02 28.2 9.98E-01 3.25E-01 5.38E+01 
GO:0044306 neuron projection terminus 0.8 6.89E-02 28.2 9.98E-01 3.25E-01 5.38E+01 
Table 28. Cellular Component GO term analysis for the regulators gene-set
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